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AUSTRIA, STYRIA -FULL MEMBER History and Funding
The registry was set up in 1986 after the Chernobyl disaster. It registers fetuses/babies with congenital anomalies born after January 1, 1985. The registry has been a member of EUROCAT since 1995. It is funded by research grants provided by the Styrian Government on an annual basis.
Population Coverage
The registry covers all births to residents of the province of Styria (population-based I 5 all mothers resident in defined geographic area), which amounts to a total of approximately 10,000 births annually. See Table 1 for coverage of European birth populations.
Sources of Ascertainment
Pediatric cardiology centers supply systematic case lists and diagnostic details to the registry.
There is one central cytogenetic laboratory in Styria that covers the whole population and provides a list of all abnormal prenatal and neonatal karyotypes annually. The registry has no direct electronic link to cytogenetics, but has close contact almost every day. So the local cytogenetic database can be used easily, although indirectly.
The registry operates as a research program with voluntary participation of hospitals. Information is gathered from 48 sources once per year. Sources consist of 11 obstetric departments, 2 pathology services, 2 child health services with specialized departments for diagnosis and treatment, and 1 cytogenetic laboratory. Fortyeight percent of cases are reported by more than one source. In the remaining 52% of cases, only one source provided data. Since 2002, most of the information is gathered electronically (see below). Fetuses/babies with anomalies are registered if diagnosed before birth, at birth, or during the first year of life.
Maximum Age at Diagnosis
Up to 1 year of age.
Terminations of Pregnancy for Fetal Anomaly
Terminations of pregnancy after prenatal diagnosis of congenital anomalies are registered. (Termination of pregnancy for socio-economic reasons is legal up to 12 weeks postconception. It requires special counseling.)
For terminations of pregnancy for fetal anomaly (TOPFA), there is no upper limit of gestational age by law, if serious psychological or health problems for the mother or the fetus were to be expected, and labor has not started. But if a non-lethal congenital anomaly is diagnosed late, most obstetricians in Austria would follow the maternal wish for TOPFA only up to the end of 23 weeks' gestation. Thereafter, pregnancies with severe anomalies, but with a viable fetus, may be terminated after fetal analgesia and feticide, if a commission agrees with the maternal wish to terminate. Non-viable forms of congenital anomalies may of course be terminated at any stage of gestation.
Stillbirth and Early Fetal Deaths
Stillbirths with congenital anomalies are registered. Stillbirth definition by law is late fetal death from a crown foot length >5 35 cm and from January 1, 1995, a limit of >5 500 g.
There is no lower gestational age or weight limit for registration of congenital anomalies in early fetal deaths/ spontaneous abortions. Autopsy rates in 1999 were as follows: stillbirths 63%, induced abortions 68%, early neonatal death (0-7 days) 70% (estimate), later deaths 1 week to 1 year 70% (estimate), and almost all deaths with congenital anomalies.
Exposure Data/Availability
Exposure information (e.g., maternal occupation, intake of drugs, or illnesses during pregnancy) is not available. Data about techniques of prenatal screening (ultrasound, serum markers) and prenatal diagnosis are systematically collected. Maternal residency is recorded and can be used for evaluating the subregional pattern of birth defects.
Denominators and Controls Information
Information on all births is available from birth certificates, registered nationally by Statistics Austria. Table 2 Published Papers Resulting from EUROCAT Projects (May 2010) cists, surgeons, pathologists, and the center for detection of metabolic diseases are also contacted for more information. Pediatric cardiology centers supply diagnostic information when requested by the registry for specific cases. Cytogenetic information is gathered on the cases suspected with a genetic anomaly. All cases with a congenital anomaly diagnosed prenatally or in the first year of life are registered. Reporting by hospitals and health workers is voluntary.
Maximum Age at Diagnosis
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is registered. Termination of pregnancy is legal under 13 weeks. If congenital anomaly is diagnosed, the upper gestational age for termination is 23 to 24 weeks.
Stillbirth and Early Fetal Deaths
The stillbirth definition for denominators is: a baby which is not viable with a gestational age of >180 days. Stillbirths are registered. Early fetal deaths and spontaneous abortions with a gestational age of less then 20 weeks are not registered.
Exposure Data Availability
Exposure information includes maternal drug use, maternal smoking and alcohol abuse, maternal and paternal diseases and family history, and parental occupation.
Denominators and Controls Information
Background data on births are retrieved from the population databases of the local authorities and from the study center for perinatal epidemiology in the Flanders region. Controls are not included in the registry, but data can be ascertained for specific studies.
Ethics and Consent
The registry's procedure was presented to the Belgian privacy committee. In this procedure, it was agreed that the registry provides information to the parents on aims and methods of registration, data protection, and the right to opt-out. If the parents do not opt-out, the data are registered. The registry does not require ethics committee approval to operate. No additional ethics committee approval is required for studies that use nonidentifiable data.
Information on the registration of congenital anomalies is given to the parents by medically qualified staff treating the child and other health care professionals treating the child.
Electronic and Web-based Data Capture
Not available.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) Registratie van aangeboren afwijkingen, Rapport 1989 to 2008, 2010 .
Registry Contribution to EUROCAT Collaborative
Papers (2007) (2008) (2009) (2010) Table 2 shows the registry contribution to EUROCAT studies.
Population Coverage
The registry annually covers approximately 12,000 births in the provinces of Hainaut (East) and Namur (populationbased II 5 all mothers delivering within defined geographic area, irrespective of place of residence), which represented about 11% of all births in Belgium.
abortions are included if the gestational age is greater than or equal to 20 weeks (weight is not a factor). Early fetal deaths/spontaneous abortions are registered. Autopsy rates are as follows: stillbirths 52% for all cases (95% of cases of malformations), induced abortions virtually 100%, early neonatal deaths (0-7 days) 52% for all cases (95% of cases of malformations), later deaths 1 week to 1 year unknown, and deaths with congenital anomaly 48% in 1992 to 1994 compared to 25% in 1982.
Exposure Data Availability
Exposure information: all that concerns information of maternal diseases during pregnancy, maternal drugs, occupations, and genetic data is available.
Denominators and Controls Information
Background data on births are available from national and regional institutes of statistics. It is also based on our own statistics in collaboration with the Center of Human Genetics. Recently, a collaboration with the Centre d'Epidemiologie Périnatale has been initiated.
Registration for EUROCAT network started in the Children's University Hospital Zagreb in 1983, after the preliminary favorable results of the pilot project on congenital anomaly registration. Collection and transmission of data was on a voluntary basis until the year 2000. After 2000, congenital anomaly registration was funded within the scientific project dedicated to epidemiologic surveillance of congenital anomalies, supported by the Ministry of Science, Education, and Sports of the Republic of Croatia.
Population Coverage
The registry is population based (population-based I 5 all mothers resident in defined geographic area). The registry covers northwestern Croatia -two regions at the seaside (Pula and Rijeka), and two continental provinces (Varaždin and Koprivnica). Births take place in four regional hospitals with practically no homebirths (only by accident). Total number of monitored births per year in these regions is around 7500, approximately 17.14% of the total annual births in Croatia. In 2009, we have started a pilot project in two additional delivery units: Vinkovci and Split, with the prospect to extend registry coverage in next years for additional 13% of annual births.
Sources of Ascertainment
In four maternity units, Varaždin, Koprivnica, Rijeka, and Pula, neonatologists and gynecologists record cases with congenital anomalies among livebirths, stillbirths, and terminations of pregnancies. Birth and stillbirth certificates include notification of congenital anomalies and are used as additional sources of information as well as hospital discharge lists.
Part of the population (local registry Rijeka) is covered by the pediatric cardiology diagnostic center. Children born in this neonatal unit have the cardiac ultrasound newborn screening. The pediatric cardiology center does not supply case lists with details and diagnostic details to the registry. In other local registries, there are no pediatric cardiology centers, but children suspected of having cardiac defects are referred to a pediatric cardiologist for evaluation. Cardiac ultrasound and diagnosis are made by a pediatric cardiologist. Data about patients with congenital heart defects are then collected by neonatologists employed in neonatal units and referred to the registry.
The Zagreb registry, at present, does not have direct access to cytogenetic laboratories. In local registries, personnel get data from cytogenetic and molecular laboratories, and, in case of death, from postmortem examination.
Maximum Age at Diagnosis
Maximum age at diagnosis is up to 1 week.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is regulated by Croatian law in 1978 (NN/18/78). The upper limit for termination of pregnancy for serious fetal anomaly is 24 gestational weeks.
Stillbirth Definition and Early Fetal Deaths
Official stillbirth definition in Croatia is 22 completed gestational weeks/500 g weight. The registry collects data about stillbirths and fetal deaths/spontaneous abortions from 20 weeks. The local registries also record results of autopsy of all termination of pregnancies after prenatal diagnosis, stillbirths, and early neonatal deaths (0-7 days). Autopsy rates in these cases are generally high, around 90 to 100%.
Exposure Data Availability
Exposure information includes: data on parental occupation, maternal drug use, maternal smoking and alcohol abuse, and maternal diseases before and during pregnancy.
Data about techniques of prenatal screening (ultrasound, serum markers) and assisted reproduction methods are collected as well and are available for most of the recorded cases.
Denominators
Information on annual births and maternal age distribution is obtained from the population databases and statistical units of the local authorities.
Ethics and Consent
To collect and store data, the registry requires ethics committee approval from the Ethics Committee of the Children's University Hospital Zagreb and Ethics Committee of Medical School University of Zagreb. Approval is renewed every 5 years.
National legislation will probably require informed consent to register a baby with a congenital anomaly in the near future. At present, the registry collects data as hospital statistics needed for public health planning; for this we do not need informed consent for each case.
There is a possibility of case identification at the local level to avoid duplicate registration, to allow updating of information or diagnosis, and to assist children and their families in the future. The Zagreb Registry sends anonymous computerized data with a local serial number for each case for the use in communication with the local registries to the Central Registry. Safety measures are established to prevent unauthorized use of the records.
Electronic and Web-based Data Capture
The Zagreb registry does not receive electronic data or perfom web-based data capture.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) The Zagreb registry is a part of the referral center of the Ministry of Health and Social Welfare for Surveillance of Congenital Anomalies in the Republic of Croatia, located at the Children's University Hospital Zagreb. Activities in our registry include:
Epidemiologic surveillance of congenital anomalies in Croatia. Center of expertise for rare genetic disorders in children -diagnostics (including clinical evaluation, cytogenetic, and molecular testing), multidisciplinary care for children affected with genetic disorders, and genetic counseling of families at risk. Primary prevention of congenital anomalies (investigation of fetal alcohol syndrome and use of folic acid supplementation in Croatia 
Registry Contribution to EUROCAT Collaborative
CZECH REPUBLIC -ASSOCIATE MEMBER

History and Funding
The unofficial registration of congenital anomalies started in 1961 but the official population-covering registration in former Czechoslovakia started in 1964. The registration itself is compulsory and financed by the Government (Ministry of Health). The registry joined EUROCAT in 2009.
Population Coverage
The registry is population-based. Currently the Czech Republic is consisting of 13 regions and the capital, Prague (with regional status). The regions can be further divided into 76 districts in total. The population of the Czech Republic is approximately 10,509,377 inhabitants (March 31, 2010) . The annual number of livebirths has increased to the current annual 120,000 livebirths (119,570 livebirths in 2008) .
Sources of Ascertainment
The registry has multiple sources. The cases of the congenital anomalies are reported via the official reporting form. The reporting form is filled in by the medical doctor who first diagnosed the anomaly -most of the reports come from delivery units, pediatric and neonatology departments, departments of medical genetics (including cytogenetic and molecular-genetic laboratories), departments of ultrasound diagnostics, and surgery departments (cardio surgery, plastic surgery). Pediatric cardiology centers supply systematic case lists and some diagnostic details to the registry. Cytogenetic laboratories provide reports on both prenatally and postnatally diagnosed cases of congenital anomalies. All diagnoses from the XVII chapter of the ICD-10 (group Q00-Q99) are reported. We do not receive the verbal description of the reported anomalies, nor do we receive the complete lists of pathologic karyotypes from cytogenetic laboratories. The ICD-10 (sub)code is the key. The age limit for the registration is 15 years; the prenatally diagnosed cases, cases in stillbirths, and cases in spontaneous abortions weighing over 500 g are also reported.
The reporting forms are collected in the Institute of Health Information and Statistics of the Czech Republic (UZIS CR, http://www.uzis.cz/), where the data are cleaned and the central database is created. The National Registry of the Congenital Anomalies is the part of The National Health Information System of the Czech Republic administered by UZIS. The reporting of a congenital anomaly is compulsory and does not require an informed consent.
Termination of Pregnancy
Termination of pregnancy is legal in the Czech Republic. After the 12th week of gestation, the termination of pregnancy is limited to the genetic indications. After the 24th week of gestation, the pregnancy can be terminated only if the mother's life is at risk.
Stillbirth Definition and Early Fetal Deaths
Stillbirth definition: non-viable fetuses, >28 weeks and >1000 g of weight. Early fetal deaths/spontaneous abortions definition: fetuses showing no signs of life, <28 weeks and <1000 g of weight, or fetuses showing one or more signs of life but <500 g and not surviving 24 hours after birth.
Cases in stillbirths and some cases in spontaneous abortions weighing over 500 g are also reported.
Exposure Data Availability
Maternal and paternal age and occupation, drugs in pregnancy (coded with the ATC (Anatomical Therapeutic Chemical classification system)), gravidity, and parity order.
Denominators and Controls Information
The information on all newborns born in the Czech Republic is available in the Czech Statistical Institute (http://www.czso.cz/) and Institute of the Health Information and Statistics of the Czech Republic (UZIS). The following information is available: birth weight, birth length, maternal and paternal age, birth date, and birth place. 
Registry Description References
Ethics and Consent
The registry does not require ethics committee approval to collect and store data. Ethics committee approval is only required for some projects that use identifiable registry data (more complex studies, where other data sources are used).
National legislation does not require informed consent to register a baby with a congenital anomaly. Data from the National Registry of Newborns and from the National Registry of Mothers are also used. These registries do not require informed consent for data collection. Data collection is compulsory according to the internal law of the Ministry of Health of the Czech Republic.
Electronic and Web-based Data Capture
The registration process is based on the paper forms and paper reports. The electronic/web-based data collecting system is in preparation.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) Calda P, Sípek A, Gregor V. 2010. Gradual implementation of first trimester screening in a population with a prior screening strategy: population based cohort study. Acta Obstet Gynecol Scand 89:1029-1033.
Gregor V, Sípek A, Calda P, et al. 
DENMARK, ODENSE -FULL MEMBER
History and Funding
The registry started in 1979 and joined the EUROCAT network from the beginning of EUROCAT. The registry has been approved by the ''Data Tilsynet'' as a private registry for the purpose of research. There is no specific funding.
Population Coverage
The registry covers the island of Funen with surrounding small islands, situated in the middle of Denmark (population-based I 5 all mothers resident in defined geographic area). The total number of births per year in Funen County is around 5600. Births take place in three hospitals with homebirths <1% of all births.
Sources of Ascertainment
The registry is based on active case finding. Data sources for the registry include electronic discharge and outpatient diagnosis from obstetric and pediatric departments, obstetric and pediatric hospital records with data on surgeries, and examinations performed on the cases (x-ray, magnetic resonance scans, and echocardiography), birth notifications, death certificates, postmortem examinations, and data from the cytogenetic laboratory.
The registry receives an annual list of all abnormal karyotypes diagnosed prenatally.
The outpatient list of diagnosis from the pediatric department includes diagnosis from the pediatric cardiology center.
Maximum Age at Diagnosis
Up to 5 years for cases seen at a pediatric department.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal before 12 weeks gestation without special permission. After 12 weeks of gestation, termination of pregnancy may be performed after permission from a local committee. If a congenital anomaly is diagnosed, the upper gestational age for termination is usually before viability. If a lethal malformation is diagnosed after fetal viability, it may be possible to have permission to induce the birth. Terminations of pregnancy for fetal anomalies are registered in the EUROCAT registry.
Stillbirth Definition and Early Fetal Deaths
From the beginning of the registry, stillbirth definition was gestational age !28 weeks. From April 2004, the stillbirth definition was changed to gestational age !22 weeks. Stillbirths and fetal deaths/spontaneous abortions from 20 weeks are registered in the EUROCAT registry. The autopsy rate in stillbirths is around 70%.
Exposure Data Availability
Exposure information: maternal occupation, medication during first trimester, maternal illness before and during pregnancy.
Denominators and Controls Information
Data on births per year and maternal age distribution covering Funen County is available from National Danish Statistics (www.statistikbanken.dk). 
Registry Description References
Ethics and Consent
The registry does not require ethics committee approval to collect and store data. The registry needs official approval for the database www.datatilsynet.dk.
National legislation does not require informed consent to register a case with a congenital anomaly.
FINLAND -ASSOCIATE MEMBER
History and Funding
The national Malformation Register was established in 1963 and regular monitoring started in 1977. In 1974, the registry became a full member of the International Clearinghouse of Birth Defects Surveillance and Research (ICBDSR), and in 1998, it became an associate member of EUROCAT. The registry system (data collection) has been changed three times, in 1985, in 1993 and in 2005 . The activities of the registry are regulated by specific law and statute on national health care registers that hold personal data. It is run and financed by THL (the governmental National Institute for Health and Welfare), under the Ministry of Social Affairs and Health.
Population Coverage
The registry is national and population-based I: all mothers resident in defined geographic area. All births in Finland are covered, representing approximately 60,000 births annually. Selective terminations of pregnancy and spontaneous abortions with malformations have been included since 1993.
Sources and Ascertainment
Notification to the registry is compulsory. Reports are obtained from delivery units, neonatal, pediatric and pathology departments, death certificates, and cytogenetic laboratories (confirmation of the cases). The Pediatric Cardiology Center operating all pediatric heart defects supplies systematic case data with diagnostic details to the registry. Case information is also received from the national Medical Birth Register, Abortion Register, Hospital Discharge Register, and the Cause-of-Death Register. The diagnoses of the malformation cases received from other sources are confirmed from the hospitals. Informa-tion on malformations is principally collected up to 1 year of age, but later information is also included. Aggregated data is transmitted to ICBDSR and EUROCAT.
Maximum Age at Diagnosis
Up to 1 year of age for surveillance purposes, but later diagnoses are also registered.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal. Termination of pregnancy for fetal reasons (severe congenital anomaly, other birth defect, or disease) can only be granted by a special permission from the National Supervisory Authority for Welfare and Health (Valvira). At the gestational age from >20 1 0 up to 24 1 0 weeks, termination of pregnancy can only be granted by Valvira's permission when a severe fetal malformation or disease has been detected by reliable prenatal diagnostics.
Stillbirth Definition and Early Fetal Deaths
Prior to 1987, stillbirths of 28 weeks or more were registered. At present, stillbirths of at least 22 weeks of gestation (!22 1 0) or 500 g of birth weight (!500 g) are registered. All notified early fetal deaths have been registered since 1993 but are only included for transmission to EUROCAT if >20 1 0 gestational weeks.
Exposure Data Availability
Before 1986, extensive exposure information was obtained from maternity health centers and by personal interview for selected malformations and their controls. From 1987 to 1992, only parental occupation was reported. Exposure information, like maternal occupation, medication, x-rays, and diseases, has been obtained since 1993. Some exposure information on all births is also available in the Medical Birth Register since 1987.
Denominators and Controls Information
Epidemiologic background data are available on all births in the Medical Birth Register and in the Statistics Finland.
Registry Description References
More information on the registry can be found in the THL website in English: http://www.thl.fi/statistics/congenitalmalformations.
Ethics and Consent
According to the Act on Nationwide Health Care Registers and the Person Data Act, no informed consent is needed for collection of identifiable case data into the national health care registers (these registers are specified by the law and statutes). Thus, no informed consent is required to register a baby with a congenital anomaly into the registry. It is not allowed for the registry to contact the registered persons or their families. Because of the legislation, ethics committee approval to collect and store data in the national health care registers is neither required. It is obligatory for the health care personnel to notify the malformed cases.
It is possible to use the case data in the national health care registers for scientific studies with specific permission from the register administrators (governmental authorities like THL). The data protection authority also gives a statement on each study. Studies using only register data from national registers 1/-hospital registers do not require ethical approval, but while it is not obligatory, it usually is highly recommended. Encrypted unidentifiable data are always preferably given out by THL instead of identifiable case data.
FRANCE, ILE DE LA REUNION -FULL MEMBER
History and Funding
The 
Population Coverage
The registry is population-based III which is all mothers delivering in Isle of Reunion excluding non-residents. The registry covers an average of 14,650 births per year.
Sources of Ascertainment
Reporting is voluntary. Notification of cases to the registry comes from hospitals and other private institutions. Ascertainment is assisted by active searching of patient notes by registry staff. Ascertainment of cases by hospital doctors is thought to be virtually 100%. Sources include maternity units, pediatric departments, prenatal screening, pathology laboratories, cytogenetic laboratories, medical genetics, pediatric surgery, and cardiology units. Cases are registered if diagnosed before birth, at birth, or during the first year of life. All malformed babies are followed up until 1 year of age, especially cases with cardiac and urinary malformations, but ascertainment of these cases may be incomplete if the malformation is not prenatally diagnosed or the case is not seen at a hospital.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy has been legal in Isle of Reunion since 1975 and recorded by the registry since 2002. There is no upper limit on gestation age at termination. Information on terminations is provided by official legal pluridisciplinary prenatal diagnosis centers. There is a national prenatal screening policy.
Stillbirth Definition and Early Fetal Deaths
The official stillbirth definition is: gestational age >20 weeks of pregnancy. Gestational age of 14 weeks is the lowest age to be included as a fetal death/spontaneous abortion in the register. Autopsies may be carried out on stillbirths, early fetal deaths, and termination of pregnancies.
Exposure Data Availability
Exposure data (occupation of mother, assisted conception, illness before and during pregnancy, and drug use throughout pregnancy) are routinely recorded to a good degree of completeness and accuracy.
Denominators and Controls Information
National birth statistics are obtained from INSEE, the National Institute of Statistics and Economic Studies. Denominators can be provided by both maternal age and monthly distribution. Information is not available on controls.
Ethics and Consent
We propose a consent to parents before registration, with a respect of anonymous case, and without ethic approval. Informed consent is asked.
Electronic and Web-based Data Capture
Electronic and web-based data capture is not available for the registry.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) Bourdial H, Jamal-Bey K, Randrianaivo H, et al. 
Registry Contribution to EUROCAT Collaborative
Papers (2007) (2008) (2009) (2010) 
Population Coverage
Until 2000, the registry population included all women residing in greater Paris (Paris and its surrounding suburbs) who delivered a baby in Paris maternity units (38,000 annual births). Beginning in 2001, the Paris population data for EUROCAT included only women residing in Paris and delivering in a Parisian maternity unit. The estimation of the coverage of the registry is around 95%.
Sources of Ascertainment
Notification to the registry is voluntary. Reports are actively collected from delivery units, pediatric departments, cytogenetic laboratories, and pathology departments. Terminations of pregnancy are included. Case information is also received from the health certificates of the first week of life, the maximum age at diagnosis. Birth certificates include notification of congenital anomalies and are used as a source of notification. The registry systematically (at least once a year) consults the three main cytogenetic laboratories in Parisian hospitals.
By far, most cases of major congenital heart defects (CHDs) are diagnosed by specialized pediatric cardiology departments in our population or by prenatal ultrasound and/or autopsy reports for pregnancy terminations and fetal deaths. In addition, pediatric cardiology centers supply diagnostic confirmation when requested by the registry for specific cases.
Maximum Age at Diagnosis
Up to 1 week of age (or later if discharged from a maternity ward at a later date).
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal and there is no upper gestational age limit for termination after diagnosis of congenital anomaly. All terminations of pregnancy regardless of the gestational age at termination are registered.
Stillbirth Definition and Early Fetal Deaths
Stillbirths of 22 weeks after the last menstrual period or more are registered. Early fetal deaths/spontaneous abortions are registered and included when the gestational age is 16 weeks.
Exposure Data Availability
Information on maternal drug use, maternal and paternal diseases and occupations, and outcome of previous pregnancies, is available for the malformed cases.
Denominators and Controls Information
Background data on births are available from the National Institute of Statistics (INSEE). 
Registry Description References
Ethics and Consent
The registry requires ethics committee approval from the French National Committee of Freedom and Informatics (CNIL) to collect and store data. Review of procedures regarding confidentiality of data of the Paris Registry is overseen by both the French National Committee of Registries and the French National Committee of Informatics and Freedom.
The registry is allowed to register cases without explicit written consent of parents. Information letters are sent to chief of services for them to post in waiting rooms, patient rooms, or other areas of the maternity ward to inform parents that anonymous data are recorded for cases of congenital anomalies.
Electronic and Web-based Data Capture
None at this time.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) Our previous studies included population-based evaluations of prenatal diagnosis and pregnancy terminations for Down syndrome (Khoshnood et al., 2008; BJOG, 2004 , Am J Public Health, 2004 , Am J Public Health, 2006 . In particular, we examined socioeconomic differences in the prenatal diagnosis and livebirth prevalence of Down syndrome. We also studied trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with CHDs (Khoshnood et al., 2008; Pediatrics, 2005) .
Our main focus of research activities in the coming years will be on CHDs and particularly analysis of a cohort study of outcomes for children with CHD (the EPICARD study). We are also looking at the prevalence, prenatal diagnosis, and pregnancy terminations for CHD in both our registry data and in EPICARD. Another project is focused on studying the risks associated with assisted reproductive technologies; two ongoing studies are related to CHD and neural tube defects. We will also pursue our studies of the modalities of prenatal testing for Down syndrome and for CHD, in particular population-based evaluations of the performance of various prenatal tests/strategies of testing, in our population.
Registry Publications (2007) (2008) (2009) (2010) 
Registry Contribution to EUROCAT Collaborative
Population Coverage
The registry is population-based II where all mothers delivering within a defined geographic area, irrespective of place of residence. Approximately 1.5% of non-resident mothers deliver within the registry area. 
Sources of Ascertainment
Notification to the registry is voluntary. Reports are collected from multiple sources: maternity unit records, pediatric records, cytogenetic laboratory, pathology laboratory, child health services, specialized departments for medical genetics, pediatric surgeons, and birth notifications. We have difficulties accessing the pediatric cardiology department of one hospital in our region. Consequently, there will be some cases that are not reported. Active registration is performed by four data collectors assigned specifically to about 35 sources each. Confirmatory sources: every year a list of abnormal karyotypes is sent by cytogenetic laboratories, and copies of pathology reports are systematically sent to the registry if malformations are present. At least more than 145 sources collaborate with the registry. Infants up to the age of 1 year old are registered, as well as fetuses delivered after medical abortion. A cutoff for notification is applied: for children born in year x, notifications are taken into account until March x12. There is no followup procedure. Children are notified when noticed by the persons in charge of data collection in hospitals. The following specific anomalies are excluded: balanced chromosomal anomalies, pyloric stenosis, metabolic disorders, minor malformations (small angiomas or naevi, hip subdislocation, small foot deformities, ill-defined facial anomalies, and inguinal and umbilical hernias). Aggregated data is transmitted to EUROCAT.
Maximum Age at Diagnosis
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal and there is no upper gestational age limit for any cause whatsoever. In the case of termination after diagnosis of a congenital anomaly, agreement is sought from a multidisciplinary committee. Terminations for fetal malformation have been registered since 1985. Notification of terminations of pregnancy is provided by obstetric units, cytogenetic laboratories, and pathology reports.
Stillbirth Definition and Early Fetal Deaths
Currently, stillbirths and early fetal death/spontaneous abortions are registered from 20 weeks' gestation onward. Before 1997, stillbirths were registered at 28 weeks or more after the last menstrual period. Stillbirth and infant death certificates are not routinely available as a source. Autopsy rates for spontaneous abortions are not registered, stillbirths 90%, induced abortions 90%, and early neonatal deaths (0-7 days) 80%. These numbers are only available to the registry as autopsy rates for malformed infants/fetuses. Most autopsies of stillborn babies are performed by a fetal pathologist.
Exposure Data Availability
Information on maternal and paternal occupation, drug use, and diseases is collected by interviews of the mothers of the malformed infants. This is not transmitted to Central Registry. No controls are interviewed.
Denominators and Controls Information
Birth statistics are provided by the National Institute of Statistics. The same population definition is used for the birth statistics except for induced abortions. Some background information is also available from the general population statistics. No information on controls is collected.
Registry Description References
See the description in the following link: http:// www.invs.sante.fr/beh/2008/28_29/beh_28_29_2008.pdf.
Ethics and Consent
The registry does require ethics committee approval to collect and store data and this approval comes from the Commission Nationale Informatique et Liberte (CNIL) 1 Comite Consultatif du Traitement de l'Information Recherche en Sante. Approval has to be checked or renewed when there is a change in the database.
National legislation requires informed consent to register a baby with a congenital anomaly. Parents have to ask for removal of the child from the register (opt-out).
The registry does not receive any electronic downloads. Nurses or midwives gather data on a daily or weekly basis in public and private hospital units using a laptop computer. To address the problem of security and management of the database, the registry decided to delegate the installation, configuration, hosting, maintenance, and monitoring of the server to the company Altitude Telecom, which provides a dedicated high security server REMERA. An integrated REMERA ''all web'' system has been developed internally to better meet the requirements of the profession, the aim being to have a unique up-to-date register reference available at all times to authorized persons. This highly secure intranet consists of management applications and query options to the database of registry tables and references (medical and geographical).
Like any web solution, it is based on a client/server system. The server is a DELL 1950 1U Linux housed in a clean room on a site with secure access, with proactive supervision, a 99.9% availability rate, 4H guaranteed recovery time, and with progressive and corrective maintenance. A production environment and an environment of pre-production exist and separate daily backups are performed.
Exchanges between client and server takes place through a virtual private network that guarantees the sealing of data traffic flow. We also use the web applications in secure mode, which requires a certificate of authenticity of the client and encryption. In addition, all personal information is encrypted in the database.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) 
Registry Contribution to EUROCAT Collaborative
Papers (2007) (2008) (2009) (2010) ) Table 2 shows the registry contribution to EUROCAT studies.
FRANCE, STRASBOURG -FULL MEMBER History and Funding
The registry was started in 1979 and became a member of EUROCAT in 1982. The registry has been officially recognized by the French National Committee of Registries in 2007 for the next 3 years (2008) (2009) (2010) . It is partially supported by an annual grant from INSERM and Institut National de Veille Sanitaire (Institute for Health Surveillance).
Population Coverage
The registry is population-based III and includes all mothers delivering in the covering area, excluding nonresidents. A total of 3.5% of non-residents give birth in the covered hospitals and 2% of the residents deliver outside the area. Up until 2004, the geographic area covered by the registry was the ''Department of Bas-Rhin'', Northeastern France, including Strasbourg, and covered about 13,500 births. Since 2005, the geographic area concerns the two departments of Alsace, ''Bas-Rhin'' and ''Haut-Rhin'', including urban and rural areas. The registry covers about 23,000 births which represents approximately 3% of all births in France.
Sources of Ascertainment
Registration is active. Sources of information are multiple including reports obtained from pediatricians, hospital discharge records, maternity records, fetal ultrasound screening, laboratory records (cytogenetic, molecular, and pathology), and specialized departments. Birth certificates include notification of congenital anomaly and are also used as a source of notification. The registry has direct access to cytogenetics laboratories; the laboratories do not S66
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send data, but all prenatal and postnatal karyotypes are actively verified. Concerning heart malformations, there are two pediatric cardiology departments. The lists of all consultations including date and place of birth and parental address, age at the time of consultation, and diagnosis are easily available and compared to other pediatric or surgical reports.
Maximum Age at Diagnosis
Up to 2 years of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal and there is no upper gestational age limit set for either social terminations or terminations as a result of a diagnosis of a congenital anomaly. Terminations of pregnancy are registered.
Stillbirth Definition and Early Fetal Deaths
Before 1993, stillbirths were defined as 180 days, and since 1993, the definition has been set at 22 weeks of amenorrhea (20 weeks of gestation) gestation. There is no limit with regard to either gestational age or weight that impedes notification of a fetal death/spontaneous abortion to the registry. Stillbirths and fetal death/spontaneous abortions are registered. All autopsies are carried out by fetopathologists.
Exposure Data Availability
Information on maternal drug use, maternal and paternal diseases and occupations, and outcome of previous pregnancies is available for the malformed cases. The children are followed to the age of 2 years old.
Denominators and Controls Information
Background data on births are available from the National Institute of Statistics (INSEE).
Ethics and Consent
The registry does not require ethics committee approval to function but has approval of both Comite Consultatif du Traitement de l'Information Recherche en Sante and CNIL.
Individual parental consent is not systematically asked for but a parental information form is available in all care units.
Electronic and Web-based Data Capture
Our electronic database corresponds to the EUROCAT Data Management Program (EDMP) with some minor local modifications. Moreover, we collect data from several electronic sources of information:
Electronic database from gynecologists named DIAMM (Dossier Informatisé Adaptatif Monde Méd-ical). Local website from Strasbourg Hospital.
Registry Contribution to EUROCAT Collaborative
GERMANY, MAINZ -FULL MEMBER
History and Funding
The Mainz Model was launched in 1990. The aim of this screening project was to determine prevalence and etiologic causes of birth defects. The registry and its asso- 
Population Coverage
The registry covers births in three maternity hospitals which serve the Mainz district and area of Rheinhesse (370,000 inhabitants; population coverage 94.7% in 2008 according to federal statistics office) of Rhineland-Palatinate in southwest Germany with approximately 3300 births per year. Births to non-residents of the area are excluded (population-based III).
Sources of Ascertainment
The registry employs three pediatricians specially trained in clinical genetics, neonatology, and pediatric ultrasonography who examine each baby born in the participating hospitals twice within the first week of life. Routine sonography of hips and kidneys are performed. For particular indications (e.g., microcephaly or heart murmur) further ultrasound examinations of the heart, the brain, and other investigations are made. Both major and minor anomalies are recorded according to a standard examination protocol, but only major anomalies are transmitted to the EUROCAT Central Registry. Information concerning stillbirths and terminations of pregnancy (voluntary) are also obtained from pathology reports. Information concerning terminations of pregnancy is obtained from pathology reports and from the one center in the district doing the final prenatal diagnosis. Cases of microcephaly are not transmitted to the EUROCAT Central Registry. Cases of hydronephrosis are available in more detailed diagnoses. Karyotyping in all suspicious and prenatally diagnosed cases in the monitored area is initiated by the registry. All cytogenic laboratory results are available for all relevant cases. All cases with prenatally detected signs or relevant medical history, as well as all suspicious children (clinics, persisting cardiac murmur for more than 3 days), are referred to the cardiology department for diagnosis. Pediatric cardiology centers supply diagnosis when requested by the registry.
Maximum Age at Diagnosis
Up to 1 week of age.
Termination of Pregnancy for Fetal Anomaly
Terminations of pregnancy after prenatal diagnosis are registered. Terminations of pregnancy for fetal malformation are performed in one of the hospitals and included in the data. It is relatively common for prenatal diagnosis of congenital anomalies not to result in a decision to terminate the pregnancy. Sixty percent of terminations have an autopsy examination as this is on a voluntary basis and these are not legally registered.
Stillbirth Definition and Early Fetal Deaths
The official stillbirth definition in Germany is a baby born with no signs of life weighing >5 500 g. The registry records information on all fetal deaths (including both stillbirths and spontaneous abortions) from 16 weeks' gestation. Autopsy rates were as follows in 1995: in stillbirths 70%, in induced abortions 70%, in early neonatal deaths (0-7 days) 55%, in later deaths 1 week to 1 year -not applicable, and in deaths with congenital anomaly -not known.
Exposure Data Availability
Exposure information on the EUROCAT form is obtained for both malformed and non-malformed babies. Sources: the pregnancy pass filled out throughout pregnancy by the obstetrician and his staff and data collected by midwives 6 to 8 weeks before birth. Additional exposure data is held which is not transmitted to EUROCAT. Drugs are ATC coded.
Denominators and Controls Information
There is comparable information on all non-malformed babies in the population from the same process of pediatric examination and information gathering. The number of births is taken from this database. Information on the total number of fetal deaths from 16 weeks is available and included in ''stillbirth'' statistics.
Registry Description Reference
Queisser-Luft A, Stolz G, Wiesel A, et al. 2002 . Malformations in newborn: results based on 30,940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) . Arch Gynecol Obstet 266:163-167.
Ethics and Consent
Informed consent to use all routinely acquired data for scientific research is part of the admission contract between the patient and the hospital and thus given (optin).
The registry requires approval from the ethics committee of Rhineland Palatinate since its beginning. The approval does not have to be checked or renewed periodically. The registry includes only pseudonymous data. An approval of the data protection committee is necessary ever since.
Electronic and Web-based Data Capture
Electronic data capture has been designed, planned implementation is scheduled in 2011.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) Birth defects in the vicinity of nuclear power plants (2006-2009, under review 2010 Registry Contribution to EUROCAT Collaborative Papers (2007) (2008) (2009) (2010) 
Population Coverage
The registry started in 1980 in the city of Magdeburg with about 4000 annual births. After that, there was a successive enlargement of the registry from 1981 to 1986. In 1981, we expanded to include some rural districts around the city of Magdeburg and this process continued until 1987 when we registered the whole area of the former ''District of Magdeburg'' (about 17,000 births per year). Then we had a stable system from 1987 to 1989, and then in 1990 there was a dramatic political change. Since the reunification, there has been a two-third decrease in the number of births in the so-called`neẁ Federal states of Germany. After the reunification, a similar process of territorial enlargement took place. In the year 2000, registration expanded to the entire Federal State of Saxony-Anhalt (21 districts and 3 major cities). In the year 2007, a reform reduced the 21 districts to 11 districts.
Saxony-Anhalt has 2.375 million inhabitants (March 31, 2009) and annual births at a rate of about 17,200 children (2009) .
By comparison to 1987, we currently survey a much larger area in our registry with approximately twice as many inhabitants but the births rate is the same as the 1980s. Registration concerns deliveries within surveyed regions excluding non-residents (population-based III).
Sources of Ascertainment
Multiple sources, such as delivery units (January 1, 2010: 27 clinics), pediatric departments, laboratories, prenatal diagnostic centers, departments of pathology, and other specialities report children/fetuses with malformations and healthy children as a control group.
The registration of a child requires the informed consent of the parents. The registration sheet does not include much personal identifiable data, thus making follow-up investigations almost impossible. Exposure information of the mother (including drug intake before and during pregnancy, including periconceptional folic acid intake) and the father is documented on a standardized documentation sheet. From 1987 onward, cases are registered if diagnosed with a congenital anomaly up to 1 year of age. The registry receives some results from cytogenetic laboratories but not through direct access or via electronic transfer. Some are received indirectly via gynecology or pediatric notes.
We get notification from the pediatric cardiology department and a regional cardiology outpatient clinic via our standardized form twice a year.
Maximum Age at Diagnosis
Termination of Pregnancy for Fetal Anomaly
Terminations of pregnancy (''medical indication'') have no time limitation by law in Germany. We have had complete information about terminations of pregnancy after prenatal diagnosis of fetal malformations since 1987.
Stillbirth Definition and Early Fetal Deaths
Stillbirths and spontaneous abortions with malformations from 16 weeks gestation are registered. The stillbirth definition has been >5 500 g from January 4, 1994, and >5 1000 g before 1994.
Exposure Data Availability
Maternal and paternal occupation, drugs in pregnancy (ATC coded), alcohol, nicotine, and drug abuse.
Denominators and Controls Information
Statistics on the total number of births comes from Statistical Office Saxony-Anhalt. There is the opportunity to exclude non-resident mothers with assistance of the postal code. A woman who gives birth outside SaxonyAnhalt, but is a result here is included in the statistics. The denominators include only livebirths and stillbirths. Information about maternal age for all births is available at the level of the entire state of Saxony-Anhalt and also the single counties.
Information is also reported about two control infants per malformed child. The two control infants, theoretically, are those born directly before and directly after the malformed child. The information about the control children is the same as malformed because a standardized documentation sheet is used.
Additional Services
Since January 8, 2006, the Malformation Monitoring Center is collecting and tracking the results of the newborn hearing screening in Saxony-Anhalt. This test is made regular in the delivery units.
We closely collaborate with the newborn screening center Saxony-Anhalt which is located at the Medical Faculty of Otto-von-Guericke University Magdeburg.
An annual report is available with results of malformation interpretation, newborn hearing screening, and newborn metabolic screening (in German). The report can be downloaded from our website. 
Registry Description References
Ethics and Consent
The registry has the ethics committee approval from the Medical Faculty, Otto-von-Guericke University, Magdeburg.
Because of the data protection law in Germany, since 1992, national legislation requires informed consent to register a baby with a congenital anomaly. Parents have to agree to the inclusion of the child on the Register (opt-in).
Electronic and Web-based Data Capture
The registry does not receive web-based data because of the data protection law.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) Lindinger A, Schwedler G, Hense HW, for the participants of the PAN study. 2010. Prevalence of congenital heart defects in newborns in Germany: results of the first registration year of the PAN study (July 2006 
Registry Contribution to EUROCAT Collaborative
IRELAND, CORK, AND KERRY -FULL MEMBER History and Funding
The registry started in 1996 and was granted approved membership of EUROCAT in 1998. The Clinical Research Ethics Committee of the Cork Teaching Hospitals approved the registry for research. Staffing includes a parttime nurse/researcher plus a part-time specialist in public health medicine and surveillance scientist support. The Department of Health and Children through the Health Services Executive provides funding for the registry.
Population and Coverage
The registry covers the counties of Cork and Kerry in the southwest of Ireland (population-based, all mothers resident in a geographic area). In 2002, <1% of resident mothers gave birth outside the registry area. The total number of births each year is around 9950.
Sources of Ascertainment
The registry is based on active case finding. Data for the registry includes hospital records from obstetric and neonatal departments, antenatal and orthopedics outpatient letters, pediatric cardiology center (local outreach clinic), supplies systematic case lists, and diagnostic details to the registry, Hospital In-patient Enquiry Data (HIPE), birth notifications, stillbirth certificates, CSO data on deaths in children up to the age of 2 years and postmortem examinations. There is no direct access to a cytogenetics laboratory.
Maximum Age at Diagnosis
Seven years of age (this is under review at present).
Termination of Pregnancy for Fetal Anomaly
Abortion is illegal in Ireland. However, women in Ireland have the option to travel outside of Ireland for termination of pregnancy after prenatal diagnosis. Where information is available to the registry about these cases, they are included.
Stillbirth Definition and Early Fetal Deaths
Babies born without signs of life with a gestational age of >5 24 weeks or a weight of >5 500 g are registered.
Early fetal deaths/spontaneous abortions are not registered. National autopsy rates for stillbirths and early neonatal death (0-7 days) have decreased due to controversy arising from the issue of consent.
Exposure Data Availability
Information on parental occupation, maternal drug use, smoking and alcohol use, illness during pregnancy, and outcome of previous pregnancies is gathered.
Denominators and Controls Information
Denominator data is available from the national CSO. The CSO now publishes national perinatal statistics in respect of all births annually and provides rates for the Republic of Ireland and is broken down by county.
Registry Description Reference
http://www.lenus.ie/hse/bitstream/10147/68034/1/Congenital%20Anomalies%20Newsletter%20%28final%29.pdf.
Ethics and Consent
Approval is required from an ethics committee representing medical, paramedical, legal, lay, and academic interests and is reviewed as indicated. Additional approval would be required for any studies that require identifiable patient data or the merging of data sources. To date, no such studies have been done. National legislation does not require informed consent to register a baby with a congenital anomaly. No plans to introduce a requirement for informed consent -in accordance with long established practice for longitudinal population-based registers. Balance is in favor of public interests as minimal individual risk.
Electronic and Web-based Data Capture
Electronic download from: 1. HIPE once a year with 2 year delay. 2. CSO -Stillbirth certificates once a year with a 3 year delay and vital statistics data once a year with a 1 year delay.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) No journal articles, book chapters, or books. A local newsletter is published.
Registry Contribution to EUROCAT Collaborative
IRELAND, DUBLIN -FULL MEMBER History and Funding
The registry was established in 1979 and joined EURO-CAT in 1980. The registry is located within the Quality and Clinical Care Directorate (Health Intelligence) of the Health Service Executive. Staffing includes a full-time pediatric nurse/researcher and a specialist in public health medicine who works part-time with the registry. In addition, there is limited secretarial support. Funding is provided by the Department of Health through the Health Service Executive.
Population Coverage
The registry is population-based I, which includes all mothers resident in the Health Service Executive area covering the counties of Dublin, Wicklow, and Kildare in the east of Ireland. A little more than one-third (25,000 births) of all births in Ireland occur in the area of coverage.
Sources of Ascertainment
There is surveillance of all livebirths and stillbirths. Children with a congenital anomaly are included in the registry when diagnosed up to the age of 5 years. Multiple sources of ascertainment are used, including information from maternity and pediatric hospitals, governmental vital statistics, medical genetics services, and hospital discharge information. As a consequence of data protection restrictions, most of the data used by the registry in the ascertainment of cases is anonymized. This is more a passive process than the active approach formerly used by the registry. As such, the use of multiple sources of ascertainment is, therefore, essential in the verification and validation of cases, but is more time consuming and has led to a time-delay in the ascertainment of many categories of anomaly. There is no electronic data access or transfer by the registry from data sources, nor web transfer process. The registry receives an anonymized case list with diagnoses from the local pediatric cardiology center; the center would include virtually all cases resident in the registry catchment area. The cytogenetic center within the region supplies an annual anonymized list to the registry of samples tested, with karyotyping and diagnostic details. The center includes the majority of samples tested within the registry population, although not all.
Maximum Age at Diagnosis
Up to the age of 5 years.
S72
Birth Defects Research (Part A) 91:S51ÀS100 (2011)
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy for congenital anomaly is not legal in Ireland.
Stillbirth Definition and Early Fetal Deaths
Early fetal deaths/spontaneous abortions are not registered. National autopsy rates only were available for 1999 for the following: stillbirths 50 to 60% and early neonatal death (0-7 days) 50 to 60%. There has been a decrease in the proportions having an autopsy in the registry catchment area to approximately 50% due to controversy arising from the issue of consent.
Exposure Data Availability
For each malformed infant reported, very limited or no information is given on certain exposures.
Denominators and Controls Information
Denominator data are supplied by the government body -the CSO. No information is available on controls.
Ethics and Consent
The registry operates according to Data Protection Legislation in Ireland/European Union. As the data on the vast majority of cases held by the registry are received on an anonymized basis, no consent is currently sought or required. No data are provided to third parties and any reports or papers using registry data are on an aggregate basis.
New national legislation on information governance in relation to all health data (including that obtained and held, and analyzed by registries) will be published by the Irish Government in late 2010. The legislation will provide the basis for the obtaining and use of all aspects of data/information, including ethical and confidentiality considerations. The precise contents of the Bill in relation to congenital anomaly registries were unknown by mid-2010, although submissions were made by the registry during the prior consultation period.
Electronic and Web-based Data Capture
The registry does not have access to electronic data held by other organizations. Likewise, there is no electronic data transfer, nor web transfer process, to the registry from its data sources.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) The main activity of the registry is to monitor trends and clusters on an ongoing basis in its catchment area. The registry has also been involved for many years in a number of collaborative research projects with EURO-CAT and the International Clearinghouse for Birth Defects and Research, and has co-authored a number of research articles.
At a local level, the registry has carried out surveys on the use of folic acid by women in the periconceptional period, consequent to a high birth prevalence of neural tube defects historically in Ireland. The findings are documented in a number of journal publications in past years.
The registry has also examined the epidemiology of a number of other congenital anomalies over the past that have shown changes in trend or have been of special significance in an Irish context, including Down syndrome, gastroschisis, and neural tube defects.
Registry Contribution to EUROCAT
Collaborative Papers (2007) (2008) (2009) (2010) The registry collaborates on a regular and ongoing basis with EUROCAT in research projects on congenital anomalies and related issues. Recent collaborative published articles resulting from such research are shown in Table 2 . 
Address for Further Information
IRELAND, SOUTH EAST -FULL MEMBER History and Funding
The Southeast Ireland Congenital Anomaly Register was established in the year 2000 and data was retrospectively collected from 1997 onward. The Department of Health and Children funds the registry through the HSE.
Population Coverage
The registry is population-based and includes babies born to all mothers resident in the southeast. The registry covers approximately 6500 births per year, which represents 11% of all births in the Republic of Ireland.
Sources of Ascertainment
The registry is based on active case findings. A child with a malformation, born after January 1, 1997, can be registered at any age. There is no upper age limit imposed for registration of a case.
Multiple sources of data are used in ascertainment and verification of cases. They include:
Child Health Information System. Death and Still Birth Certificates. Postmortem Examinations. Disability Care Allowance systems. Hospital Inpatient Enquiry System (HIPE). Cytogenetic Laboratories -no direct access, information received on an annual basis. Information from maternity and pediatric hospitals.
Pediatric cardiology centers do not supply information to the registry, but other sources of information cover pediatric cardiac surgery (i.e., copies of letters from pediatric cardiology centers in respect of each case are always available in medical notes at hospital level).
Medical notes are reviewed in each instance to assist in the confirmation of the diagnosis.
Registration covers babies born with prenatally diagnosed anomalies, affected fetuses spontaneously lost from 24 weeks gestation, or with a birth weight >500 g.
EUROCAT guidelines are adhered to in respect of inclusions and exclusions.
There has been a decrease in the proportions of stillbirths and early neonatal death (0-7 days) having an autopsy, due to controversy arising from the issue of consent.
Maximum Age at Diagnosis
There is no upper age limit.
Terminations of Pregnancy for Fetal Anomaly
Induced abortions are illegal in Ireland. We do not currently obtain information about terminations of pregnancy for fetal anomaly carried out under other jurisdictions.
Stillbirth Definition and Early Fetal Deaths
Registration covers affected fetuses spontaneously lost from 24 weeks' gestation or with a birth weight >500 g.
Exposure Data Availability
Maternal health, drug, and lifestyle exposure data is collected primarily from pediatric medical records.
Denominators and Controls Information
Denominator data is available from the national CSO.
Ethics and Consent
The registry requires ethics committee approval to collect and store data. This approval was sought at the time of setting up the registry and there has been no requirement for renewal of the approval.
Currently, consent is not obtained for inclusion of cases on the register. Women are given information antenatally, telling them about the register. New legislation (The Health Information Bill) due to be published in autumn 2010 will place new requirements on registers in the areas of data protection and consent.
Electronic and Web-based Data Capture
We currently have three electronic downloads of notifications:
1. HIPE (Hospital inpatient enquiry) system. We receive HIPE downloads on cases of congenital anomalies as soon as the data has been collected and quality audited at hospital level. This is conducted in a timely manner, for example, 2008 year's data will be available to us within the first 6 months of 2009. Any cases that do not have a confirmed diagnosis at that stage will be followed up by registry staff at a later date. 2. Cytogenetic laboratory electronic reports. We receive electronic reports on neonates, infants, and older children from the cytogenetic laboratories on an annual basis via another registry. 3. Oral clefts. We receive electronic reports on neonates and infants on an annual basis from a tertiary referral hospital that specializes in these cases.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) In addition to data collection and transmission to EUROCAT Central Registry, and contribution to studies via EUROCAT Central Registry, the Southeast Ireland registry is involved in educational activities, is linked in with EUROPLAN activities in Ireland, and is part of a national group with the other Irish EUROCAT registries under the auspices of the HSE National Directorate for Quality and Clinical Care. 
Registry Contribution to EUROCAT Collaborative
ITALY, EMILIA-ROMAGNA -FULL MEMBER
History and Funding
The registry started its activities in 1978 with the participation of a few collaborating centers rising to cover all delivery units in the region.
Since 1980, the registry is recognized and supported by the Emilia-Romagna region with the following objectives:
To produce prevalence data on congenital malformations. To provide temporal and spatial surveillance and management for alarms. To conduct studies to evaluate health interventions (pre-natal and neonatal screening). To provide a reference center, both clinical and epidemiologic, for congenital malformations.
The registry joined EUROCAT in 1980 and in 1981 transmitted the first birth year of data to EUROCAT. The registry joined the International Clearinghouse for Birth Defects in 1995. The Emilia-Romagna Registry also participates in the coordination of the Italian Congenital Malformation Registries set up by The Italian National Institute for Health (l'Istituto Superiore di Sanità) with the aim of sharing the experiences of the various registries, create common lines of research, and produce epidemiologic data on congenital malformations at a national level (http://www.iss.it).
Since 2003, the registry has been in collaboration with the health information systems service and social policy body of the Emilia-Romagna region formally involved in the Scientific Steering Committee.
In 2004, a link with the Regional Medical Genetics Service network was formed (www.geneter.it) with the aim of providing genetic counseling and evaluating genetic conditions diagnosed within the network.
Population Coverage
The Emilia-Romagna region covers an area of 22,123 square killometers with a population of around 4 million people. The total number of births in the Emilia-Romagna region is growing with 42,397 births in 2008. The registry includes in its coverage the Republic of San Marino with 349 births in 2008.
The program is population-based II (includes all mothers delivering within the region of Emilia-Romagna, irrespective of place of residence). In 2008, 92 .3% of births were to resident mothers. Since 2006, the registry, in collaboration with the Regional births database (CeDAP) has reached a population coverage $100% involving all 34 delivery units in the region. In recent years, immigration has created an important demographic change with an increase in births. The births to non-Italian citizens represented 26.1% of the total births in the region in 2008.
Sources of Ascertainment
The Emilia-Romagna Registry has multiple sources of ascertainment:
1. Voluntary hospital participation. Reporting is carried out using the Emilia-Romagna Registry form by neonatologists, pediatricians, and obstetricians during the first week of the infant's life. We do not have specific notification from pediatric cardiology units. Pediatric cardiology centers supply diagnostic confirmation when requested by the registry for specific cases. Notification of a congenital anomaly is recorded up to 1 week. Selected malformations are followed up (e.g., Down syndrome, cardiovascular defects, and clefts). The clinical activities and genetic counseling conducted by medical geneticists who form part of the registry staff provides an opportunity to stimulate colleagues to notify cases. 2. The Regional Births database (CeDAP) also provides the registry with a source of denominator and control data. 3. The hospital discharge database Scheda di Dimissione Ospedaliera (SDO) provides further sources of ascertainment. This source can be used to investigate pediatric surgery cases for specific studies.
Birth certificates do not notify congenital anomalies. Death certificates do not allow for the notification of a congenital anomaly as a cause of death. We do not currently have direct access to cytogenetic laboratory results across the region but we are working toward this objective with the Regional Health Authority.
Maximum Age at Diagnosis
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy became legal in Italy in 1978. Termination is legal when there is no possibility of autonomous life for the fetus. The Italian law (L.N. 194/ 78) states that termination is allowed in the case of diagnosis of serious fetal pathology which may detrimentally affect the woman's physical or psychological health. The upper gestational age limit for terminations is 23 weeks. Induced abortions after prenatal diagnosis of birth defects are systematically included. Data for induced abortions first became available in 1982.
A ministerial decree (decreto 10.09.1998 GU no. 245 del 20.10.98) details a protocol covering laboratory and diagnostic tests for pregnant women (ultrasound, amniocentesis, chorionic villus sampling, and AFP/triple test). Three ultrasound examinations at 10, 20, and 30 weeks gestation are foreseen in the protocol. Cytogenetic testing is provided routinely for women over 35 years of age. After genetic counseling, cytogenetic and genetic testing are offered independent of age; these services are free of charge.
Stillbirth Definition and Early Fetal Deaths
The official definition of stillbirth in this registry is now 180 gestational days in line with the Regional Births database (CeDAP). Fetal deaths of 20 weeks or more gestation are systematically included (with no lower weight limit exclusion criteria). The autopsy rates in 2008 were: $50% in stillbirths, $60% in induced abortions, $90% in early neonatal deaths (0-7 days), $90% in later deaths 1 week to 1 year, and $90% in deaths with congenital anomalies. A regional project on perinatal deaths is ongoing.
Exposure Data Availability
Exposure information is obtained by interviews of the mothers of malformed infants. From 2003, data regarding maternal drugs in the first trimester is recorded as ATC codes and jobs are recorded using the International Standard Classification of Occupations (ISCO) work codes. Previously, these data were recorded using internal codes.
Denominators and Controls Information
Birth statistics are provided by the Regional births database (CeDAP) recorded by maternal age group and birth month. This source also provides information for control cases. General demographic information is available for all births in the area (e.g., mean maternal and paternal ages, percentage of mothers 35 years or older). In recent years, immigration has created an important demographic change with an increase in births. As births to non-Italian citizens represented 26.3% of the total births in the region in 2006, the nationality of the mother is now coded for all births.
Further information regarding the reference population can be gained from the Emilia-Romagna region websitehttp://www.regione.emilia-romagna.it/index.htm.
Ethics and Consent
The registry is recognized as part of the health system information flow and regulated by regional laws. The parents have to agree to the inclusion of the child on the register (opt-in).
Electronic and Web-based Data Capture
The registry website allows the participating centers to download a pdf of the case notification form but does not allow electronic data transmission. The majority of cases (75%) are still received from neonatologists, pediatricians, and obstetricians using the paper form. The Regional Births database (CeDAP) provides the registry with a source of denominator and control data and we receive an annual download of malformed cases. In November, we receive the file of the previous year so it has an 11-month delay. We also receive an electronic download annually for terminations during the second trimester. The delay for receiving data is around 9 months from year-end. The centers are then alerted to integrate the cases with further details from this summary data. Around 20% of cases are provided by this source. We do not receive regular downloads of data from the hospital discharge database (Scheda di Dimissione Ospedaliera) but we can request data for specific studies.
Registry Contribution to EUROCAT Collaborative
Registry Staff and Computing
Professor Elisa Calzolari -Registry Leader (part time). Dr. Gianni Astolfi -Database management (full time). Dr. Amanda J Neville -EUROCAT coordinator (part time).
ITALY, TUSCANY -FULL MEMBER History and Funding
The registry started in 1979 in the province of Florence and from 1992 in the whole Tuscany region. The registry is a surveillance program included in the Regional Statistics System; it is formally recognized and supported by the Tuscany Region Health Authority. The registry joined EUROCAT in 1979.
Population Coverage
The program is population-based I which includes all mothers resident in the region of Tuscany. It involves all the regional hospitals and the coverage is around 95% of all births in the Tuscany region (approximately 3.5 million inhabitants and 29,000 births per year). Exchanges between regional informative systems indicate that 3.3% of resident mothers gave birth in a hospital outside Tuscany in 2007.
Sources and Ascertainment
Multiple sources are used to ascertain malformed infants; records are obtained from all obstetrical and maternity units, pediatric departments, pediatric cardiology departments, pediatric cardiac surgery units, prenatal diagnostic centers, medical genetics units, and pathology services. Pediatric cardiology centers covering part of the registry population supply systematic case lists and diagnostic details to the registry. Cytogenetic laboratories only confirm karyotype for cases already known. Mothers are interviewed by using a standardized questionnaire. Malformed babies diagnosed within the first year of life are also registered.
Maximum Age at Diagnosis
S76
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy became legal in Italy in 1978. Termination of pregnancy is legal when there is no possibility of autonomous life for the fetus. The Italian law (L.N. 194/78) lays down that termination is allowed in the case of diagnosis of serious fetal pathology which may detrimentally affect the women's physical or psychological health. Induced abortions after prenatal diagnosis of birth defects are systematically included. Data for induced abortions first became available in 1982.
Stillbirth Definition and Early Fetal Deaths
The official definition of stillbirth in this registry is 180 gestational days. Fetal deaths of 20 weeks or more gestation are systematically included, with no lower weight limit exclusion criteria.
Exposure Data Availability
Maternal and paternal occupation, life-style and socioeconomic characteristics are obtained by interviews of mothers of malformed infants.
Denominators and Controls Information
Vital statistics and other epidemiologic information is obtained by the birth medical records collected by the Regional Bureau of Statistics. Selected information is obtained from the control material collected.
Ethics and Consent
The registry does not require ethics committee approval to collect and store data.
At the moment informed consent is not required by national legislation, but the registry asks for oral authorization from the mother, the parents have to agree to the inclusion of the child on the register (opt-in).
Electronic and Web-based Data Capture
Until 2009, personal and diagnosis information were transmitted separately by hard copy; from 2010, appointed gynecologists, neonatologists, and/or pediatricians of the maternity units and the centers of Pediatrics, Medical Genetics, Pediatric Cardiology, and Pediatric Cardiosurgery have a personal account and send data via web. Sensitive data are kept separate from medical information. For security, data are encrypted and transmitted across the internet network using the secure http protocol HTTPS, instead of the standard HTTP.
Registry Contribution to EUROCAT Collaborative
MALTA -FULL MEMBER
History and Funding
The registry started in 1985 as a research project of the University of Malta. It started as a hospital-based register collecting data regarding congenital anomalies diagnosed in babies born at the main general hospital. It became a member of EUROCAT in 1986. Funding for the research project was stopped in 1995, and in January 1997, the Department of Health Information resumed the functions of the registry increasing coverage to all hospitals on the islands making it a national population-based register. The registry is now run and funded by the Government Department of Health Information and Research. The aim of the registry is to provide accurate epidemiologic information regarding the occurrence of congenital anomalies in Malta and Gozo.
Population Coverage
The registry is population-based 1: covering all resident mothers in Malta, Gozo, and Comino, and presently covers about 4000 births per year. The number of resident mothers giving birth in a hospital outside the area is considered to be negligible as Malta is an island and population movement is limited. It is unlikely that mothers will go abroad to give birth. It is precisely for this reason that the registry is considered to cover close to 100% of births.
Sources of Ascertainment
Reporting is voluntary. Several new sources of information have been used since 1997 and the registry has S77 EUROCAT ORGANIZATION AND ACTIVITIES backdated its information to include these sources of information from 1993. For this reason, data since 1993 may be considered most complete and reliable. The registry now uses active data collection from multiple sources including delivery, obstetric, and pediatric wards, pediatric echo cardiology records, genetic clinics records, National Mortality Register, National Obstetric System database, Hospital Activity Analysis database, National Cancer Register, and the hypothyroid screening program. Voluntary reporting by doctors is also available. These sources cover the whole population of the Maltese Islands. Registry staff regularly visits the pediatric echo cardiology department to go through their records and identify cases. Consultant geneticists send the registry a list of positive genetic results on an annual basis.
Babies with a congenital anomaly may be diagnosed and registered up to 1 year of age. Minor anomalies (as defined by EUROCAT) are not registered unless in combination with other major defects. There is no legal requirement for notification of congenital anomalies without parental consent.
Maximum Age at Diagnosis
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is illegal in Malta.
Stillbirth Definition and Early Fetal Deaths
The official definition of stillbirth is a baby born with no signs of life at gestational age of 22 weeks or more, or a birth weight equal to or >500 g. Stillbirths are registered. All early fetal deaths of 20 weeks' gestation and over which have been diagnosed as having a congenital anomaly are included. Autopsy rates for 2009 were 57% for stillbirths and 32% for infant deaths.
Exposure Data Availability
Information regarding maternal disease and exposure to medicinal drugs, smoking, alcohol and drug abuse, as well as parental occupation are collected for all malformed infants.
Denominators and Controls Information
Epidemiology background data on all births are available from the National Obstetric Information Systems database and the National Statistics Office.
Registry Description Reference
https://ehealth.gov.mt/HealthPortal/strategy_policy/ healthinfor_research/registries/birth_defects.aspx.
Ethics and Consent
The Superintendant of Public Health, within his legal responsibility, requires that a Malta Congenital Anomalies Register be kept in the interest of public health (DH circular 36/09). Ethics committee approval is needed before data is released for individual studies, projects, or theses.
Malta became a member of the European Union in 2004 and complies with directive EC95/46. There is no national legislation requiring informed consent to register a baby with a congenital anomaly.
Electronic and Web-based Data Capture
Not yet available.
NETHERLANDS, NORTH -FULL MEMBER History and Funding
EUROCAT Northern Netherlands started in 1981, and was a member of the EUROCAT network since that year. The registry is funded by the Dutch Ministry of Health, Welfare, and Sports and is associated with the Department of Genetics of the University Medical Centre of Groningen (UMCG).
Population Coverage
The registry is population-based, including all mothers resident in the registration area. In the beginning, the program covered 7500 births annually in the province of Groningen and the northern part of the province of Drenthe. From 1989 onward, coverage was gradually increased to 20,000 births annually in the provinces of Groningen, Friesland, and Drenthe. In recent years, the number of births in the region decreased to 18,500, approximately 10% of all births in The Netherlands. Home deliveries (35% of births per year) are included and it is estimated that only a few percent of resident mothers would give birth outside the defined registry area.
Sources of Ascertainment
Children and fetuses with congenital anomalies diagnosed before or after birth are eligible for registration at the EUROCAT Northern Netherlands registry, if the mother lived in the region at the time of birth and the child has not reached the age of 16 at notification. There is no lower limit for gestational age, spontaneous and induced abortions are included. Notification of children and fetuses with congenital anomalies is voluntary. Registry personnel are actively involved in case ascertainment, using multiple sources such as obstetric records, hospital administration data, and pathology records. Cytogenetic laboratory results are electronically downloaded from the genetics department and include all abnormal karyotype reports, both from prenatal and postnatal samples. For cases reported to the registry, it is verified whether any genetic tests were performed and test results are registered in the database. The only pediatric cardiology center in the registration area, also part of the UMCG, supplies systematic case lists and diagnostic details to the registry. A number of frequently occurring mild anomalies is not registered unless they occur in combination with other serious congenital anomalies. If new information becomes available for registered children before 16 years of age, the files are updated.
Maximum Age at Diagnosis
Up to 16 years of age.
Termination of Pregnancy for Fetal Anomaly
TOPFA is legal. The upper age limit for termination of pregnancy (for social reasons and for fetal anomaly) is 24 weeks, based on the viability criteria. Termination of pregnancy after 24 weeks is allowed when the fetus is affected with a congenital anomaly that is considered lethal.
Stillbirth Definition and Early Fetal Deaths
A stillbirth is defined as a fetus of at least 24 weeks' gestation that died in the uterus or during birth. There are no age or weight limits for inclusion of early fetal deaths/spontaneous abortions. Autopsy rates per year are not available.
Exposure Data Availability
Since 1997, parents have been asked to fill out a questionnaire including questions on occupational activities, smoking habits, alcohol consumption, recreational drug use, and socioeconomic status. In addition, data from community pharmacies are used to collect data on medication dispensed in the period from 3 months before and during pregnancy. After the information of the pharmacy is received, a telephone interview with the mother is done to verify whether she has actually taken the medication dispensed from the pharmacy and if she has taken any over-the-counter medication. The response rate to the questionnaire is 80%.
Denominators and Controls Information
General statistics are available from the Central Bureau of Statistics. No information on non-malformed infants is collected.
Ethics and Consent
The registry does not require ethics committee approval to collect and store data. The registry operates within the scope of the Dutch data protection act (Wbp) and the Code of Good Conduct, set up by the Dutch Federation of Biomedical Scientific Societies. National legislation requires informed consent to register a baby with a congenital anomaly. Parents have to agree to the inclusion of the child on the register (opt-in). The positive response rate is 80%.
Electronic and Web-based Data Capture
Although the ascertainment of cases uses electronically derived lists of children with certain clinical diagnoses or cytogenetic laboratory results, no automatically electronic or web-based data capture has been implemented so far.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) The research activities are focused in particular on knowledge and use of folic acid and its protective effect on congenital malformations and on medication use in pregnancy. Selected local publications in international journals include:
Bakker van Beynum IM, Kapusta L, Bakker MK, et al. 2010 . Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registrybased case-control study in the northern Netherlands. Eur Heart J 31:464-471.
Registry Contribution to EUROCAT Collaborative
NORWAY -FULL MEMBER
History and Funding
The program ie, the Medical Birth Registry of Norway was started in 1967. The program is run and funded by the governmental National Institute of Public Health. The registry joined EUROCAT in 1998.
Population Coverage
The program is population-based and covers all mothers delivering within Norway, irrespective of place of residence, with approximately 58,000 annual births. Nonresident mothers delivering with the registry area account for approximately 0.2% of all births.
Sources of Ascertainment
Reporting to the registry is compulsory. The registry is based on the notification of births from the delivery units and, since 1999, also from the neonatal units for infants transferred to such units after birth. Congenital anomalies are registered up to 1 year of age and there is no maximum age for registration of mortality. Autopsy reports are collected for stillbirths with birth weight >500 g, and for TOPFAs where autopsy has been done.
The Medical Birth Registry of Norway (MBRN) does not currently receive direct notification from cytogenetic laboratories or specific notification from pediatric cardiology departments.
Maximum Age at Diagnosis
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal and is the mother's decision up to 12 weeks' gestation. After 12 weeks' gestation, permission is required from the commission and these have been recorded from 1999 onward. If a congenital anomaly is diagnosed, the upper gestational age limit is 18 weeks (with exemptions). Since December 1, 1998, all TOPFAs are registered in the MBRN database. Autopsy reports are collected.
Stillbirth Definition and Early Fetal Deaths
Early fetal deaths/spontaneous abortions of 16 weeks or more were included between the years 1967 to 2001 inclusive. This has been decreased to a gestational age of 12 weeks or more from 2002 onward. Official birth rates are published for births !22 weeks (or 425 g). Autopsy rates were reported as follows: 50% in stillbirths, 50% in induced abortions, 80% in early neonatal deaths (0-7 days), 90% in later deaths 1 week to 1 year, and 80% in deaths with congenital anomaly.
Exposure Data Availability
Some basic information, such as maternal disease and, since 1999, smoking and occupation (with consent) is collected on all infants, malformed or not.
Denominator and Controls Information
All information available for the reported malformed infants is also available for the total population of births.
Registry Description Reference
Irgens LM. 2000. The Medical Birth Registry of Norway. Epidemiologic research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 79:435-439.
Ethics and Consent
Research using anonymized data from the Medical Birth Registry are exempt from institutional review board approval in Norway. All studies must be approved by the Publication board at the Medical Birth Registry.
Electronic and Web-based Data Capture
Electronic notification to the registry was made compulsory from 2006, and by June 2010 was adopted for 82% of births. Notifications are transmitted as encrypted XML messages using the ''National Health Net'' for transportation, and with unique, specific certificates for all delivery units, neonatal intensive care units (NICUs), and the Medical Birth Registry. Notifications should be sent from delivery units to the Birth Registry within the first month after birth, and is usually sent daily, depending on the size of the delivery unit. Notifications from NICUs should be sent within 1 month after discharge. Reminders of missing notifications (based on records in the Central Population Registry, to which the MBRN is routinely linked) are sent to the delivery units each month.
In September 2010, there were three different software packages in use at the delivery units providing medical birth notifications, while all NICUs providing neonatal notifications used the same software.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) The main registry activities, outside research work, have been to establish electronic notification of births from all delivery units in the country, and to rebuild the registry's local database. Electronic notification is a prerequisite for another major goal at present: to publish updated institution-specific statistics, which may be used for quality work at the institutions. Some validation studies have been done, in addition to research activities in several fields, both within obstetrics and neonatology, birth defects, genetic epidemiology, and within the field of ''fetal origin of adult diseases''.
Eskedal LT, Hagemo PS, Eskild A, et al. 2007 . A population-based study relevant to seasonal variations in causes of death in children undergoing surgery for congenital cardiac malformations. 
Registry Contribution to EUROCAT Collaborative
POLAND -ASSOCIATE MEMBER History and Funding
The Polish Registry of Congenital Malformations (PRCM) has been in operation since 1997. It was founded as a scientific project ordered by the Polish Ministry of Health and financed by the State Committee for Scientific Research. Since July 1, 2000, it has been part of the Government Programme of Monitoring and Primary Prophylaxis of Congenital Malformations in Poland, financed by the Polish Ministry of Health. As part of this program, the registry provides the Polish Ministry of Health with important information needed in health care management. In 2003, it was decided that data for the Wielkopolska region, which is part of the territory covered by the PRCM, would be transferred to EUROCAT separately and treated as full member registry data.
Population Coverage
The PRCM is a population-based registry of type I (all mothers resident in defined geographic area). 
Sources of Ascertainment
Notification is recommended by the Ministry of Health (as an official government program, however, notification is not obligatory) and consists of multi-source reporting. The sources include: delivery unit staff, ultrasound staff, postnatal ward staff, pediatric intensive care unit staff, fetal medicine unit staff, pediatricians, postmortem reports, regional genetic and cytogenetic services (direct access to cytogenetic laboratories and genetic clinic), and pediatric cardiology referral centers. The main source of information is a double-sided notifications form filled out by a physician responsible for diagnosing the malformations. The notification forms are sent immediately to the PRCM Central Working Group. Additionally, all birth records in Wielkopolska are reviewed and abstracted by trained staff with the aim of ascertainment of cases. Birth certificates do not record congenital anomalies. Death certificates allow for notification of congenital anomaly as a cause of death and, therefore, they are used as a source. Electronic and web-based data capture has been implemented (about 15% of all notifications). Well visited website www.rejestrwad.pl.
Maximum Age at Diagnosis
Termination of Pregnancy for Fetal Anomaly
Although termination of pregnancy is legal, it can only be performed by a physician when: (1) a pregnancy poses danger to health or life of the pregnant women; (2) prenatal diagnosis or other medical evidence indicates high probability of serious and irreversible damage to a fetus or it is an untreatable life-threatening disease; and (3) there is a plausible suspicion the pregnancy has arisen from a prohibited act. The upper gestational age limit for termination of a severe congenital anomaly-affected pregnancy is 24 weeks. Although the termination of pregnancy is legal, in Poland there is public pressure not to perform such a procedure and that is why the data on pregnancy terminations might be underestimated. Hence, the registry currently does not register terminations of pregnancy after prenatal diagnosis.
Stillbirth Definition and Early Fetal Deaths
The official stillbirth definition is as follows: fetal death (stillbirth) is a death before the complete expulsion or extraction of a product of conception from a mother, irrespective of pregnancy duration; the death is indicated by the fact that after separation, the fetus does not breathe, or shows no other evidence of life, such as heart beating, pulsation of the umbilical cord, or definite movement of voluntary muscles. For statistical purposes, we include all fetuses weighing at least 500 g at the moment of birth, having reached the 22nd week of gestational age, if the weight is unknown, or reaching 25 cm of the body length (crown-heel). We do not include early fetal deaths or spontaneous abortions. Autopsy rates vary between regions or even between health care units, the ranges for performance are as follows: stillbirths 10 to 30%, early neonatal deaths 20 to 30%, later deaths 1 week to 1 year 10 to 20%, and deaths with congenital anomaly 30 to 40%.
Data Availability
The following data is gathered by way of registration forms, although its availability may be limited, depending on the source of registration: chronic illness in mother, pregnancy-induced conditions in mother, acute maternal illness during pregnancy, therapeutic and recreational drugs taken during pregnancy, invasive tests in pregnancy, folic acid use in pregnancy, smoking habits, alcohol use, mother's obstetric history, the country of residence, family history of congenital malformations, and genetic conditions in family members, father's and mother's occupational and environmental hazards, and the father's and mother's education.
Denominators and Controls Information
Information on all births (live and stillbirths) is available from birth certificates gathered by the Central Statistical Office for Poland. Since 2005, information on controls has been gathered by the registry.
Registry Description Reference
Latos-Bieleń ska A, Materna-Kiryluk A, PRCM Working Group. 2005. Polish Registry of Congenital Malformations -aims and organization of the registry monitoring 300,000 births a year. J Appl Genet 46:341-348.
Ethics and Consent
The registry does not require ethics committee approval for all studies based on the registry data solely, but requires an approval for other projects (using registry data but focusing on genetic or clinical studies).
Electronic and Web-based Data Capture
Electronic and web-based data capture has been implemented (about 15% of all notifications).
POLAND, WIELKOPOLSKA -FULL MEMBER
History and Funding
The PRCM has been in operation since 1997. It was founded as a scientific project ordered by the Polish Ministry of Health and financed by the State Committee for Scientific Research. Since July 1, 2000, it has been part of the Government Program of Monitoring and Primary Prophylaxis of Congenital Malformations in Poland, financed by the Polish Ministry of Health. As part of this Program, the registry provides the Polish Ministry of Health with important information needed in health care management. In 2003, it was decided that data for the Wielkopolska Region, which is part of the territory covered by the PRCM, would be transferred to EUROCAT separately and treated as full member registry data.
Population Coverage
The PRCM is a population-based registry of type I (all mothers resident in defined geographic area). In the year 2009, Wielkopolska Region had a population of 34,083 people (8.93% of Poland) spread over an area of 29,827 square kilometers (9.54% of the Poland territory) with 41,043 births per year (livebirths and stillbirths), corresponding to 9.79% of total births in Poland.
Sources of Ascertainment
Notification is recommended by the Ministry of Health as an official government program; however, notification is not obligatory and consists of multi-source reporting. The sources include: delivery unit staff, ultrasound staff, postnatal ward staff, pediatric intensive care unit staff, fetal medicine unit staff, pediatricians, postmortem reports, regional genetic and cytogenetic services (direct access to cytogenetic laboratories and genetic clinics), and pediatric cardiology referral centers. The main source of information is a double-sided notifications form filled out by a physician responsible for diagnosing the malformations. The notification forms are sent immediately to the PRCM Central Working Group. Additionally, all birth records in Wielkopolska are reviewed and abstracted by trained staff with the aim of ascertainment of cases. Birth certificates do not record congenital anomalies. Death certificates allow for notification of congenital anomaly as a cause of death and, therefore, they are used as a source. Electronic and web-based data capture has been implemented (about 15% of all notifications). Well visited website www.rejestrwad.pl.
Maximum Age at Diagnosis
Termination of Pregnancy for Fetal Anomaly
Although termination of pregnancy is legal, it can only be performed by a physician when: (1) a pregnancy poses danger to health or life of the pregnant women; (2) prenatal diagnosis or other medical evidence indicates high probability of serious and irreversible damage to a fetus or it is an untreatable life-threatening disease; and (3) there is a plausible suspicion the pregnancy has arisen from a prohibited act. The upper gestational age limit for termination of a severe congenital anomaly-affected pregnancy is 24 weeks. Although the termination of pregnancy is legal in Poland, there is public pressure not to perform such a procedure and that is why the data on pregnancy terminations might be underestimated. Hence, the registry currently does not register terminations of pregnancy after prenatal diagnosis.
Stillbirth Definition and Early Fetal Deaths
Data Availability
The following data is gathered by way of registration forms, although its availability may be limited depending on the source of registration: chronic illness in mother, pregnancy-induced conditions in mother, acute maternal illness during pregnancy, therapeutic and recreational drugs taken during pregnancy, invasive tests in pregnancy, folic acid use in pregnancy, smoking habits, alcohol use, mother's obstetric history, the country of residence, family history of congenital malformations, genetic conditions in family members, father's and mother's occupational and environmental hazards, and the father's and mother's education.
Denominators and Controls Information
Information on all births (live and stillbirths) is available from birth certificates, gathered by the CSO for Poland. Since 2005, information on controls has been gathered by the registry.
Registry Description Reference
Ethics and Consent
Since July 2005, electronic reporting of malformations has been made possible on the PRCM website (www.rejestrwad.pl).
Currently, at least 15% of all notifications are electronic.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) Genetic studies on congenital urinary system malformations. Collaborative project with Division of Nephrology, Columbia University. PRCM main investigator -Dr. A. Materna-Kiryluk.
Identification of novel genes for limb malformations. 
Registry Contribution to EUROCAT Collaborative
PORTUGAL, SOUTH -FULL MEMBER History and Funding
The registry started in 1988 and it became a member of EUROCAT in 1989. The registry is funded by the National Institute of Health, a body within the Ministry of Health.
Population Coverage
The registry is population-based which includes all mothers resident in the regions of Algarve, Alentejo, and part of the Lisboa e Vale do Tejo Region (Setubal and part of Santarem Districts). It covers approximately 18,000 births annually representing 14% of the total number of births in Portugal.
Sources of Ascertainment
Pediatricians, obstetricians, and clinical geneticists are responsible for case notification in each region, up to the end of the neonatal period. Other sources of ascertainment are fetal pathology hospital departments. At this moment, only two pediatric cardiology departments participate in the registry, but no cytogenetic laboratory. Data are validated and coded at the central level in Lisbon.
Maximum Age at Diagnosis
Up to 1 month of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal up to 24 weeks' gestation and requires the permission of a technical committee. Non-viable anomalies have no upper limit. Terminations as results of diagnosis of a congenital anomaly are included in the registry.
Stillbirth Definition and Early Fetal Deaths
The definition is 22 weeks of gestation of 500 g. Most stillborn fetuses in the covered area have an autopsy performed. Stillbirths with congenital anomalies are included in the registry. Fetal deaths of earlier gestation or lower weight are not included.
Exposure Data Availability
Information about maternal drug use, maternal diseases, maternal occupation, and obstetric history is available for cases.
Denominators and Controls Information
Demographic information is available from the National Statistic Office.
Registry Description Reference
The operation of the registry is described in the website of the National Institute of Health.
Ethics and Consent
Data on cases is transmitted by attending doctors at hospital departments to the Central Registry and registered centrally without personal information. A specific numeric code permits linking registry data with clinical data at local levels by the attending medical doctor.
Electronic and Web-based Data Capture
Approximately 30% of all EUROCAT registries from the South Portugal region come through an electronic web-based system. Data is input at local levels by participating physicians into the central database template. This has the same variables than the paper-based questionnaire. Each participating center can use and download only data from that center. The web-based tool has data input, data analysis, and data transfer capabilities. Data from the remaining centers is received in paper and centrally input into the informatics database. Table 2 shows the registry contribution to EUROCAT studies.
SPAIN, BARCELONA -FULL MEMBER
History and Funding
The Barcelona Birth Defects Registry (Registre de Defectes Congènits de Barcelona -REDCB) was initiated in 1990 and reached a population-based status by 1992, when it became a member of the EUROCAT. The REDCB is part of the Service of Health Information Systems (Servei de Sistemes d'Informació Sanitaria) in the Public Health Agency of Barcelona (Agència de Salut Pú blica de Barcelona). It is funded by Regional (Generalitat de Catalunya) and Local (Ajuntament de Barcelona) Administrations.
Population Coverage
The REDCB is population-based and covers pregnancies of women resident in Barcelona City ending in live or stillborn babies of 221 weeks of gestation or in induced abortions (IAs) due to prenatal detection of birth defects (i.e., the registry does not include birth defects in spontaneous abortions -<22 weeks of gestation, or IAs not due to prenatal detection of birth defects).
Some 3% of residents' newborns occur at maternity units of the city limits. The REDCB controls 50% of these newborns (1.5%), delivering in a hospital near the city. Since Barcelona City is a pole of attraction for at risk pregnancies, the remaining 1.5% of newborns not controlled by the registry probably provides <1% of cases.
Currently, (2008) the REDCB covers about 14,500 births annually. In the last 5 years, the number of births has increased from about 12,500, mainly due to a higher fertility rate among immigrant women of developing countries coming to the city.
Sources of Ascertainment
General information on cases and controls, as well as clinical information on cases, is collected using questionnaires specifically made for the registry. An interview with the mother is the main source of general information. Delivery units, pediatric departments, cytogenetic laboratories, pathology departments, prenatal diagnosis units, and pediatric cardiology services are the main sources of clinical information. The registry has direct access to some cytogenetic laboratories, but not to all. Some of the collaborating laboratories send their data by e-mail, but for most of them, registry staff personally go to collect the case information.
Direct Access to Cytogenetic Laboratories Covers only Part of our Population
Pediatric cardiology centers covering part of the registry population supply systematic case lists and diagnostic details to the registry.
Maximum Age at Diagnosis
Up to 3 days of age. When a suspicion of birth defect exists, follow-up is made until a diagnosis or normality is stated. This affects mainly birth defects as CHD.
Termination of Pregnancy for Fetal Anomaly
IA after prenatal detection of a birth defect is legal in Spain until 22 weeks of gestation. A probable future modification in the Spanish IA law will affect birth defects: some fetuses with major birth defects detected in the third trimester of pregnancy (i.e., after 22 weeks) could be induced for abortion.
Case Definition
Cases are defined as fetuses or newborns with at least 1 major or 21 minor anatomic birth defects or with unbalanced chromosomal anomalies. The follow-up period is 2 to 3 days after delivery. Due in part to this short follow-up period, poor ascertainment exists for birth defects as mild hypospadias, some cardiovascular defects, and other anomalies of internal organs not detected using prenatal ultrasounds. The ascertainment of unbalanced chromosomal anomalies without neonatal anatomic defects (as some sexual chromosome anomalies like XXX, XXY, XYY) is never complete and depends on the rate of karyotyped pregnancies.
Controls Selection
A random sample (not case-matched) of about 2% of the newborns expected in each maternity unit is selected as controls.
Data Availability and Information Sending to EUROCAT
Information on maternal drug use, maternal and paternal diseases, and occupations is available for cases and controls, but it is not sending to the EUROCAT Central Registry. The REDCB systematically sends data to the EUROCAT Central Registry on all ''core'' variables but two (civil registration status and McKusick code), and on a ''non-core'' variable (karyotype).
Denominators Information
Background data on births are available from birth certificates and the Barcelona Perinatal Mortality Registry.
Ethics and Consent
The registry is located in a health authority setting (Barcelona Public Health Agency).
Parental consent is asked for during interview with the mothers of cases and controls.
Address for Further Information
Joaquín Salvador, Servei de Sistemes d'Informació Sanitària (SESIS), Agencia de Salut Pú blica de Barcelona (ASPB), Avda. Princep d'Astú ries, 63, 28, 08012 Barcelona, Spain. E-mail: jsalvado@aspb.cat.
SPAIN, BASQUE COUNTRY -FULL MEMBER History and Funding
Registration of congenital anomalies in the Basque Country started on January 1, 1990. The registry became a EUROCAT member in September 1990. The registry is financially supported by the Health Department of the Basque Government.
Population Coverage
The registry is located in the Basque Country region, in northern Spain, covering a geographic area of 7260 km 2 and a population of 2,162,944 inhabitants. It is a population-based registry that, therefore, includes all mothers delivering in the Basque Country excluding any non-residents. The average number of annual births 2003 to 2008 is 20,174. It is estimated that 1 to 2% of outside resident mothers deliver in the covered hospitals.
Sources of Ascertainment
Reporting is voluntary, although the capture of data is now systematic for 80% of cases using the automated hospital database. There is an active search for cases (livebirths, stillbirths, and induced abortions), through multiple sources of information: hospital discharge records, hospital automated data, neonatal units, specialist pediatric department, cytogenetics and pathology laboratories, and private maternity hospitals.
Pediatric cardiology centers supply diagnostic confirmation when requested by the registry for specific cases.
We do not have direct access to cytogenetic laboratories. We ask for the results personally from the geneticists at each of the hospitals involved in the registry. Usually laboratories supply the list of prenatal and infant abnormal karyotypes when requested.
Maximum Age at Diagnosis
Routinely reported to the registry up to 1 year of age.
Termination of Pregnancy for Fetal Anomaly
Since March 2010, ''sexual and reproductive health and abortion'' in Spain is governed by a new law. Termination of pregnancy is now legal for certain indications, including prenatal diagnosis of severe anomaly, at any time during pregnancy. Data about techniques of prenatal screening and diagnosis are systematically collected.
Stillbirth Definition and Early Fetal Deaths
The official definition of stillbirth in the Basque Country and Spain is a gestational age of 22 weeks or a birth weight of 500 g. Postmortem examination rates are highly variable in the region. About 90% of autopsies in stillbirths and neonatal deaths were performed in the public maternity hospitals (the remaining 10% of parents did not give permission). The autopsy rate after termination of pregnancy is high (70%), but the quality varies, depending on hospitals.
Exposure Data Availability
Information on maternal drug use, maternal and paternal diseases, outcome of previous pregnancies, and assisted conception is available.
Denominators and Controls Information
Statistics are provided by the Basque Statistics Institute (EUSTAT).
Ethics and Consent
No ethics committee approval is required to operate the registry. No approval is needed for studies that require identifiable patient data. The hospitals have an ethics committee if further ethical recommendations are considered necessary.
Legislation complies with the EC95/46 directive with respect to disease registers and surveillance since 1999.
Information about all newborns in the Basque Country is automatically collected and stored in an oracle application server. This application is the property of the Health Department of the Basque Government from which the registry can complete information for newborns with any congenital anomaly. We have unrestricted access to the application. The application follows high levels of security specified in the Official Disposition of June 17, 2005.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) The 10th European Symposium on Prevention of Congenital Anomalies was held in Bilbao (Basque Country) on June 10, 2009. We have a new registry leader since April 2010.
Registry Contribution to EUROCAT Collaborative
Address for Further Information
Larraitz Arriola, Registro Anomalías Congénitas CAV, Subdirecció n de Salud Pú blica, Av. Navarra 4, 20013 San Sebastian, Spain. E-mail: l-arriola@ej-gv.es.
SPAIN, SPAIN HOSPITAL NETWORK -ASSOCIATE MEMBER ECEMC-Spanish Collaborative Study of Congenital Malformations History and Funding
This is a research program created in 1976 by Professor Dr. María Luisa Martínez-Frías, as a hospital-based casecontrol study and surveillance system, with voluntary participation of hospitals but mandatory subjugation to the operating rules for those participating. It contributes to EUROCAT with data since 1980, and is also a member of the ICBDSR. In January 2002, the ECEMC Program became integrated into CIAC (Research Center on Congenital Anomalies), of the Instituto de Salud Carlos III (ISCIII), from the Ministerio de Ciencia e Innovació n. It is also directed by Professor Martínez-Frías. In 2006, the ECEMC was recognized as an excellent research program to be integrated into Centre for Biomedical Research on Rare Diseases. ECEMC has two teratogen information services since 1991, one for the general population and another one for physicians. The program is financed mainly by the Spanish Administration and, partially, by non-governmental organizations.
Population Coverage
Data are obtained from about 70 hospitals distributed all over Spain. The annual number of births is about 100,000, representing more than 21% of all Spanish births. Stillbirths of at least 24 weeks or 500 g have been included since 1980. Data on terminations of pregnancy due to the presence of congenital anomalies, which can be legally performed within the first 22 weeks of gestation, can only be gathered in some participating hospitals.
Sources of Ascertainment
The detection period is the first 3 days of life, including major and/or minor/mild defects. The information comes from delivery units and pediatric departments of the participating hospitals. The pediatric/neonatology units ask for specialized cardiologic evaluation of patients in whom cardiac anomalies were prenatally or neonatally suspected, and those with other congenital defects. Mothers are interviewed directly by the participating physicians during those first 3 days after the infant's delivery to fill in the ECEMC standard protocols, which include more than 310 data for each child, whether case or control. The information for each case and its control is gathered by the same physician. Controls are defined as the next non-malformed infant born at the same hospital than the case with the same sex of the malformed infant. In many instances, photographs, imaging studies, high-resolution bands karyotype, and molecular analyses when needed (which are performed at the central group of the ECEMC), and other complementary studies, are available. ECEMC's laboratory, to which the program has direct access, provides karyotype and molecular analyses for cases the program already knows about, and some registered cases are studied in external laboratories. Biologic samples are stored in the ECEMC registry for those cases for which the collaborating physicians send them, with the informed consent of the parents, for diagnosis as well as for further research.
Maximum Age at Diagnosis
Up to 3 days of age. A longer follow-up is achieved in selected cases.
Termination of Pregnancy for Fetal Anomaly
Up to 1985, termination of pregnancy was illegal in Spain. From 1985 onward, induced abortions have been legal but they are registered by the ECEMC only for some hospitals that can report them. The upper gestational age limit for termination is 22 weeks in cases of congenital anomaly.
Stillbirth Definition and Early Fetal Deaths
The official definition of stillbirth in the Spain Hospital Network is 24 weeks or later or weighing at least 500 g. Stillbirths have been included since 1980. Autopsy rates in the period from 2007 to 2009 were 58.18% for stillbirths and 22.22% for deaths with a congenital anomaly.
Exposure Data Availability
The mother of each reported infant (case or control) is interviewed within the first 3 days after delivery to obtain data on several exposures (parental occupation, maternal acute or chronic diseases, drug usage, illicit drugs, alcohol and tobacco maternal consumption, exposure to other chemical or physical factors), apart from the other data gathered (family history, obstetrical and de-mographic data, among others). It is important to note that when the pediatricians detect the cases and select the control children, they are blinded to the different maternal and family data that they are going to collect.
Denominators and Controls Information
Total number of births by sex and number of twin pairs in each participating hospital are gathered. Other background information is obtained from the control material. The information for controls is obtained with the same methodology that is used for cases (interview to the mother) and, as for cases, data on more than 300 variables are gathered.
Registry Description Reference
Martínez-Frías ML. 2007 . Postmarketing analysis of medicines: methodology and value of the Spanish casecontrol study and surveillance system in preventing birth defects. Drug Safety 30:307-316.
Ethics and Consent
The registry obtained approval to function from the Ethics Committee of the Instituto de Salud Carlos III, Ministry of Science and Innovation. National legislation requires informed consent to register a baby with a congenital anomaly. Parental consent is always asked for and parents have to agree to the inclusion of the child on the register (opt-in).
Electronic and Web-based Data Capture
Neither electronic nor web-based data capture is used in this program. All the notifications are received in paper forms from the neonatal or delivery units of the participating hospitals.
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) ECEMC, which is organized in three sections (epidemiology, genetics, and clinical teratology), maintains its international participation in EUROCAT, ICBDSR, and ENTIS (European Network of Teratology Information Services). It participates in the activities and several research projects of Centre for Biomedical Research on Rare Diseases, as one of its 61 integrating Spanish research groups. Annually, ECEMC organizes a scientific meeting with the attendance of outstanding researchers, together with representatives from the 70 collaborating hospitals in the program. During that meeting, the most burning methodological issues of the program are also discussed. Every year, ECEMC publishes a report (ECEMC s Annual Bulletin), in which some results of its activity are shown. Such bulletin (http://www.ciberer.es/documentos/ECEMC_2009_AF.PDF) is distributed among 7000 physicians (pediatricians and obstetricians) from all over Spain.
These are some selected publications of the group for the period 2007 to 2010 (the complete list can be accessed through the above detailed link to the ECEMC's Annual Bulletin):
Chabchoub E, Rodríguez L, Galán E, et al. 2007 . Molecular characterisation of a mosaicism with a complex chromosome rearrangement: evidence for coincident chromo-3, 1 a planta, 28029 Madrid, Spain. E-mail: mlmartinez. frias@isciii.es.
SWEDEN -ASSOCIATE MEMBER
History and Funding
The registry started in 1964 as a trial and was established in 1965. In 2003, the registry became an associate member of EUROCAT. The registry system (data collection) was changed in 1999. Specific laws and statutes on national health care registers, which hold personal data, regulate the activities of the registry. It is run and financed by the National Board of Health and Welfare, the governmental National Research and Development Center for Health and Welfare (under the Ministry of Social Affairs and Health).
Population Coverage
The registry is national and population-based I: all mothers resident in a defined geographic area. All births in Sweden are covered, representing approximately 100,000 births annually. Selective terminations of fetuses with malformations are included since 1999.
Sources of Ascertainment
Since 1999, the register does not receive notifications from pediatric cardiology centers. However, information from detailed cardiovascular examinations could be attached to the reports sent by the reporting unit (pediatric or obstetric department).
Notification to the registry is compulsory. Reports are obtained from departments of pediatrics, obstetrics, clinical genetics, and cytogenetic laboratories. The diagnoses of the malformed cases are often received from more than one source. Pediatric cardiology centers do not supply information to the registry, but other sources of information cover pediatric cardiac surgery. The cytogenetic information is obtained through annual reports from all cytogenetic laboratories in the country, and contains information on all prenatal and infant abnormal karyotypes.
Aggregated data are transmitted to EUROCAT.
Maximum Age at Diagnosis
Information on malformations is principally reported before 1 month of age except for congenital heart malformations, which are reported up to 1 year of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal. Termination of pregnancy for fetal reasons (congenital anomaly) can be granted after special permission after 18 weeks and up to 23 weeks of gestation from an ethical committee at the National Board of Health and Welfare.
Stillbirth Definition and Early Fetal Deaths
The definition of stillbirths in Sweden is birth after 22 weeks of gestation. Since 1999, all fetal deaths with congenital malformations >22 weeks of gestation are registered at the Swedish Registry of Congenital Malformations.
Exposure Data Availability
Exposure information on all births is available in the Medical Birth Register since 1973.
Denominators and Controls Information
Epidemiologic background data are available on all births in the Medical Birth Register and in the Statistics of Sweden.
Ethics and Consent
The registry does not require ethics committee approval to collect and store data. The register is ruled under a special law for the registers of health care run by the Swedish National Board of Health and Welfare. For investigations run by other groups of researchers than those working within the Swedish National Board of Health and Welfare, approval from ethics committee is compulsory.
National legislation does not require informed consent to register a baby with a congenital anomaly.
Electronic and Web-based Data Capture
All reports to the Swedish Register of Birth Defects are sent by paper forms (September, 2010) .
Recent Registry Activities and Publications (2007) (2008) (2009) (2010) Information from the register has been used in several publications, but this is not centrally recorded, and no publication list is available.
Annual reports have been published by the Swedish National Board of Health and Welfare in 2007, 2008, and 2009 (covering data on births/terminations in 2006, 2007, and 2008, respectively) . The 2010 annual report is in preparation covering data from 2009.
Registry Contribution to EUROCAT Collaborative
SWITZERLAND, VAUD -FULL MEMBER
History and Funding
The Registry of Switzerland was originally established in collaboration with EUROCAT in 1988. Different cantonal registries sent their data to the Central Registry in Lausanne. The aim at the beginning was to cover the whole country (80,000 births/year). In the first years of activity, 30 to 81% of births were surveyed. For financial reasons, many cantons had to stop this activity and, in 1993, the Swiss Registry covered 50% of all births in Switzerland. In 1998, the following cantons were included in the program: Zurich, Fribourg, Argovie, Tes-sin, Vaud, Valais, Neuchatel, and Jura. The registry is located in the Division of Medical Genetics in the University Hospital of Lausanne. The registry has formerly been associated with members from the Swiss Academy of Medical Sciences and from the Swiss Society of Pediatrics. The system was financed by the Swiss Federal Agency for Statistics for the Central Registry and by the cantonal health department for some cantonal registries. As the level of ascertainment was quite heterogeneous between the local cantonal registries and their activities fluctuating according to the years (cf. prevalence rate <200 per 10,000), it was decided in January 2002 to restrict the registration to canton of Vaud only and to change the name of the registry: Registry of Vaud (Switzerland).
Population Coverage
The registry is population-based I and as such it covers all mothers resident in the canton of Vaud. The percentage of mothers delivering in a hospital outside the registry area is not known precisely, although it is thought to be very low. The registry covers about 9% of all births in Switzerland (approximately 7500 births annually). The changing coverage is detailed above.
Sources of Ascertainment
Reporting is voluntary. Active case finding and multiple sources of information are used: delivery units, pediatric departments, cytogenetic and genetic counseling, and pathology units. Data about different methods of prenatal diagnosis are collected (ultrasound, serum markers, cytogenetic, and molecular).
The registry is situated in the Department of Medical Genetics and we thus have direct access to the cytogenetic and DNA laboratories; they systematically supply the registry with abnormal karyotypes and molecular studies prenatally and postnatally diagnosed.
Twice a year we contact the other laboratories covering the residual population of the canton to check for anomalies.
There is no upper age limit for registration of a child with a malformation.
Maximum Age at Diagnosis
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal up to 12 weeks' gestation under most circumstances but this limit is extended to 24 gestational weeks if a congenital anomaly is diagnosed. In the latter circumstance, additional permission must be granted by two further physicians. Induced abortions after prenatal diagnosis are included in the register.
Stillbirth Definition and Early Fetal Deaths
The official stillbirth definition is a gestation age of >5 27 weeks or length >5 30 cm, which are included in the register. Early fetal deaths/spontaneous abortions are included if they are 20 gestational weeks or more with no weight restrictions. Autopsy statistics were not available.
Exposure Data Availability
Information on maternal occupations and diseases, maternal drug use, and outcome of previous pregnancies is available for the malformed infants.
Denominators and Controls Information
Background data on births are available from the Service Cantonal de Recherche et d'Information Statistique.
Ethics and Consent
National legislation does not require informed consent to register a baby with a congenital anomaly. However, since 2007, according to a national law about genetic analysis, the parents have to sign informed consent for these analyses.
Electronic and Web-based Data Capture
We receive some data mainly from pediatricians only on a paper-based system.
We have no website notification system. chuv/genmol/eurocat/euro-home.htm (username: eurocat, password: tropic).
UKRAINE -FULL MEMBER
History and Funding
Population-based birth defects surveillance began in 2000 in the framework of the Ukrainian-American Birth Defects Program funded by the United States Agency for International Development. The program became an associate member of ICBDSR in 2001. In 2005, the United States Agency for International Development component was completed and the program was assumed by OMNINet, a not-for-profit international organization incorporated in Ukraine, and is continued as OMNI-Net Ukraine Birth Defects Program. OMNI-Net represents five resource OMNI-centers all of which provide care for children with birth defects, promote prevention programs, participate in parental organizations, and engage in collaborative programs with national and international partners.
Program objectives include universal folic acid flour fortification, methods to reduce alcohol impact on child development in collaboration with partners, and promoting international partnerships.
OMNI-Net personnel are financed from regional budgets. The legislation and rules by the Ministry of Health mandates the reporting of birth defects. Birth defect data is reported by Oblast Vital Statistics Centrum who aggregates, formats, and forwards the data to the Ministry of Health.
Population Coverage
Birth defect surveillance annually covers about 28,000 births in two oblasts (provinces) of Western UkraineRivne and Khmelnytsky, representing approximately 6% of births in Ukraine. The population is relatively homogeneous and stable (data is pooled from these two oblasts). The registry is of type III (all mothers delivering in the defined geographic area excluding non-residents of that area).
Sources of Ascertainment
Relevant hospital admission/discharge summaries are systematically reviewed. Qualified registry specialists also routinely review all medical records of regional pediatric cardiology centers and obtain ascertainment of diagnostic details. Data from specialty clinics, laboratories (including cytogenetic one), and other services are explored. Our cytogenetic laboratories are the only ones in the region and they provide us with study reports. Pregnancy, obstetrics, delivery, neonatal, and pediatrics records are reviewed. The information is substantial regarding service providers located in regional centers, but limited regarding service providers in rural environments.
Maximum Age at Diagnosis
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal and performed by a physician when: (1) a pregnancy poses danger to health or life of a pregnant woman; (2) prenatal diagnosis or other medical evidence indicates high probability of serious and irreversible damage to a fetus or it is an untreatable life-threatening disease; and (3) there is a plausible suspicion the pregnancy has arisen from a prohibited act.
Up until December 31, 2005, the upper gestational age limit for termination of pregnancy in Ukraine was 28 weeks and/or 1000 g.
From January 1, 2006, Ukraine redefined the definition and the current upper gestational age limit for termination of pregnancy is 22 weeks and/or 500 g.
Stillbirth Definition and Early Fetal Deaths
The stillbirth definition is as follows: fetal death (stillbirth) is a death before the complete expulsion or extraction of a product of conception. Until January 1, 2006, for statistical purposes, we include all fetuses weighing 1000 g or more at the moment of birth or/and gestational age above 28 weeks; spontaneous abortions include fetuses weighing <1000 g and gestational age <28 weeks.
From January 1, 2006, Ukraine redefined stillbirth definition as all fetuses weighing 500 g or more at the moment of birth and/or gestational age above 22 weeks.
In Ukraine, Certificates of Neonatal Death are NOT medical documents, they are issued by civil authorities.
Exposure Data Availability
Routine information collection is limited except when ad hoc circumstances are noted. An expansion of exposure data collection is in progress.
Denominators and Controls Information
Information on all births (live and stillbirths) is available from birth certificates gathered by the Regional Vital Statistics. There are 2 control cases for each birth defect case.
Background Information
The northern counties (rayons) of one of the two oblasts are contaminated from the Chernobyl disaster. Data regarding ionizing radiation pollution in contaminated rayons is available by special agreements. Data from a population-based neonatal registry is also available by special agreements.
Ethics and Consent
Registration of birth defects and follow-up is an integral part of health care protocols.
Electronic and Web-based Data Capture
Maternity departments transfer data on all newborns, including newborns with birth defects, to a Central Regional Newborn Registry Database every month. Webbased data capture is not used. 
Population Coverage
All mothers normally resident within South Yorkshire and the counties of Derbyshire, Nottinghamshire, Lincolnshire, Leicestershire, Rutland, and Northamptonshire, irrespective of the actual place of delivery. The annual number of births for the registry is approximately 74,000.
Sources of Ascertainment
Reporting is voluntary from multiple sources in all the hospitals across the region, including antenatal clinics, delivery suites, neonatal screening, neonatal and special care baby units, cytogenetics laboratories, clinical genetics, pathology, pediatric surgery, and departments of child health. Registration includes pre-natally diagnosed fetuses, with no lower age limit, thus including early terminations and fetal losses.
There are three cytogenetic laboratories in the region, each with a different method of communication with the registry. One laboratory provides a monthly electronic list of all abnormal prenatal and infant karyotyptes. One laboratory provides this on paper notification forms, while the third confirms karyotypes for cases already notified to the register. An annual data validation exercise is undertaken with this laboratory to identify missing cases.
The central pediatric cardiology center situated within the region provides systematic case lists and diagnostic details for all surgical and non-surgical cases to the registry on request (usually made annually). Two other cen-ters outside the registry area, covering parts of the western and southern population, supply diagnostic information for cases already known to the registry, or neighboring registers, upon request. A fourth center, also outside the region but covering part of its northern population, currently does not supply data, but is expected to routinely exchange data with EMSYCAR once the new Yorkshire CAR becomes fully operational in 2011.
There is no time limit for registration or for updating diagnostic details.
Maximum Age at Diagnosis
There is, at present, no upper age limit.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal up to 24 weeks' gestation. There is no upper gestational age limit for termination if a major anomaly is diagnosed. Terminations for anomaly reasons and anomalies found at postmortem after social terminations are included in the register.
Stillbirth Definition and Early Fetal Deaths
The official stillbirth definition is fetal death after 24 completed weeks. There is no lower gestational age or weight limit for anomalies identified in early fetal deaths.
Exposure Data Availability
Not specifically requested but recorded if relevant information is provided by the notifier.
Denominators and Controls Information
The denominator data for births in the region is provided by the Office for National Statistics on an annual basis.
Ethics and Consent
All United Kingdom registries require ethics committee approval to collect and store data. This is obtained centrally from Trent Multicentre Research Ethics Committee (NHS) and requires renewal every 5 years.
National legislation also requires informed consent, but United Kingdom registries are exempted from this by National Information Governance Board (formerly Patient Information Advisory Board, PIAG) approval. This allows the Secretary of State for Health to permit a specified dataset to be collected without individual consent. This approval requires annual renewal. All parents have to be made aware that they can request the removal of personal identifiers from their local register should they wish.
Electronic and Web-based Data Capture
Electronic downloads are received from one of three cytogenetic laboratories (monthly), and the main pediatric cardiac center (annually). All abnormal scan reports from the second largest delivery suite are received electronically, with plans for the largest unit to adopt this method during late 2010. All other notifications are paper based. EMSYCAR does not use web-based data capture.
UNITED KINGDOM, NORTHERN ENGLAND -FULL MEMBER
History and Funding
The Northern Congenital Abnormality Survey (United Kingdom, Northern England) was established in 1985 after a 1-year pilot study. The Northern England register is funded by the Healthcare Quality Improvement Partnership until April 2011. The registry is one of four databases linked through the mother's details, held at the Regional Maternity Survey Office in Newcastle -the others being perinatal and infant deaths, diabetic pregnancy, and multiple births. The Northern England register has been the source of congenital anomaly data for our reporting area for United Kingdom National Statistics from January 2003 to December 2009.
Population Coverage
The Northern England register records all congenital anomalies that occur in pregnancies of mothers' resident in North East England and North Cumbria (populationbased). This area extends from North Cumbria to the Tees area up to the Scottish border and includes North Cumbria, Northumberland, Newcastle upon Tyne, North Tyneside, Gateshead, South Tyneside, County Durham, Darlington, and Tees. Until 1994, South Cumbria was included in the reporting area. The population of the current area is approximately 3 million. The annual number of births for the registry area is currently approximately 32,000, which represents about 5% of the total births in England. Minor anomalies are not reported. The EURO-CAT list of exclusions is used.
Sources of Ascertainment
Reporting is voluntary from multiple sources. The Northern England register has a strong relationship with clinicians and non-medical staff in all the hospitals in the region. Sources of reporting include ultrasonographers, geneticists, midwives, radiographers, obstetricians, pediatricians from a wide range of specialties, pathologists, cardiologists, fetal medicine specialists, and surgeons. Cross validations with other regional databases occur regularly, including the Northern Genetics Service (cytogenetics service), the Fetal Medicine Unit at the Royal Victoria Infirmary (regional tertiary center), and the Pediatric Cardiology database at Freeman Hospital which supplies case lists and diagnostic details to the register. The registry receives quarterly downloads of all prenatal and infant abnormal karyotypes for the population of the region from the Northern Genetics Service.
Registration includes all anomalies discovered in fetuses, including early pregnancy losses and terminations after prenatal diagnosis, and babies and children up to the age of 12. The registry has extremely good ascertainment of late fetal deaths and stillbirths affected by congenital anomalies as it is run in parallel with the Northern Perinatal Mortality Survey, which was established in 1981. All registered deaths are cross-validated with U.K. National Statistics annually.
There is no time limit for updating diagnostic detail. Ascertainment of anomalies diagnosed after the neonatal period is less complete than those usually diagnosed in the neonatal period, although there is good ascertainment of all chromosomal and cardiac anomalies, whenever diagnosed. Ascertainment of ophthalmological anomalies is low. Karyotype details of cases with abnormal karyotypes are now being recorded. These are available for cases from 2004.
Maximum Age at Diagnosis
Up to 12 years of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is potentially legal, subject to proper process, for fetuses without identified anomalies up to 24 weeks' gestation. There is no upper gestational age limit for termination if a major anomaly is diagnosed that is considered to be life threatening for the newborn baby.
Stillbirth Definition and Early Fetal Deaths
The official stillbirth definition is fetal death after 24 completed weeks. There is no lower gestational age or weight limit for anomalies identified in early fetal deaths. Miscarriages under 20 weeks' gestation that have abnormal karyotypes which have not been detected antenatally and are not accompanied by structural anomalies are not included in the database.
Exposure Data Availability
We have good data on exposure to diabetes in pregnancy, due to a linked database (Northern Diabetes in Pregnancy Survey) that has run since 1995. Maternal drug exposure, whether or not they smoke, and major medical problems are recorded when available. In mid-2004, maternal weight and height data were added to the reporting form.
Denominator Information
At present, denominator data is provided by the U.K. National Statistics. There is work at the national level to provide information on gestation for all registered births, which is currently lacking.
Registry Description Reference
Richmond S, Atkins J. 2005. A population-based study of prenatal diagnosis of congenital malformation over 16 years. BJOG 112:1349-1357.
Ethics and Consent
The registry requires ethics committee approval to collect and store data and this is granted by the Trent Multi-center Research Ethics Committee. Approval is renewed annually.
National legislation requires informed consent to register a baby with a congenital anomaly. However, through its membership of the British Isles Network of Congenital Anomaly Registers (BINOCARs), the registry collects non-consented data under Section 251 of the NHS Act 2006 (originally enacted under Section 60 of the Health and Social Care Act 2001), which allows the common law duty of confidentiality to be set aside in specific circumstances where anonymous information is not sufficient and where patient consent is not practicable.
Electronic and Web-based Data Capture
The Northern England register does not have webbased data capture facilities at present. While cases are reported electronically, there is no system for uploading this information directly to the database. Therefore, information received electronically is added to the database manually. Electronic downloads of cases are received via internal secure email from the regional cleft lip and palate team (monthly) and the cytogenetic laboratory (quarterly). The cases included in these lists are the most recent available. Cases for cross validation are received from the Hospital Episode Statistics on an ad hoc basis. These are hand delivered or sent by courier on an encrypted disk or memory stick.
Population Coverage
For births 1991 to 2004 -Information is collected on all malformations suspected prenatally and/or confirmed in fetuses/babies booked for delivery at the two maternity hospitals in Oxfordshire or in the community. Cases submitted to EUROCAT must have an Oxfordshire postcode -this gives the best approximation available to the unselected local Oxfordshire population (7000 births). For births from 2005 onward -The register uses the same malformation inclusion criteria to cover the whole of Oxfordshire, Berkshire, and Buckinghamshire. This region is defined by the Local Authority boundaries that make up the three counties. The population coverage is approximately 30,000 births per annum. For 2005 births -ascertainment in Berkshire and Buckinghamshire is likely to be lower than would be expected because systems for registration were still being established. Therefore, prevalence rates will be misleading for this year.
Sources of Ascertainment
Data are obtained voluntarily from multiple sources across the region, such as antenatal clinics, obstetric ultrasound, delivery suites, special care baby units, cytogenetic laboratory, pediatric pathology, and the Down syndrome service. Information is collected on all fetuses identified antenatally with a suspected congenital anomaly or ultrasound soft marker and on all babies born with a congenital anomaly. The aim is to collect data concerning all infants aged up to age 1 year, but in practice, this is not achieved. There is under ascertainment of cardiac, orthopedic, and renal defects diagnosed after the mother has left the maternity unit and methods to improve ascertainment are being explored.
Maximum Age at Diagnosis
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal up to 24 weeks of gestation with no gestation limit for serious congenital defects. Cases are ascertained via the prenatal diagnosis unit and from postmortem reports.
Stillbirth Definition and Early Fetal Deaths
The definition of still birth is ''a child born with no signs of life after complete expulsion from the mother after the 24th week of pregnancy''. All stillbirths with a congenital anomaly are registered. Early fetal deaths/ spontaneous abortions are included with no lower gestational age limit.
Exposure Data Availability
Information is collected where it is available (not on every case) on chronic illness in the mother, details of assisted conception, invasive tests in pregnancy, and alcohol abuse.
Denominators and Controls Information
Oxford Maternity Data system provides denominator data for 1991 to 2004 births. The Office for National Statistics (ONS) provide denominators for births after 2005.
Registry Description Reference www.npeu.ox.ac.uk/carobb/annualreport.
Ethics and Consent
The registry requires ethics committee approval to collect and store data and this comes from Trent, United Kingdom for all BINOCAR. Approval is renewed every 5 years.
National legislation requires informed consent but the registry is exempt. Patient Information Advisory Group (PIAG) approval given for all BINOCAR registries. Parents have to ask for the removal of the child from the register (opt-out).
Electronic and Web-based Data Capture
There is direct access to the cytogenetic laboratory covering the whole area, providing six-monthly electronic lists of all abnormal karyotypes for prenatal and postnatal diagnoses. Pediatric cardiology centers covering part of the registry population supply systematic electronic case lists to the registry on cases undergoing surgical procedures. Monthly electronic lists of relevant pediatric admissions (by ICD10 code) are received from the tertiary referral center.
includes any baby where pregnancy ended on or after this date. The Wales Register joined EUROCAT in 1998. The register is based at Singleton Hospital, Swansea and, since October 1, 2009, became part of Public Health Wales NHS trust. The register aims to collect data that can be used to describe the pattern of congenital anomalies across Wales. This should help:
Build up and monitor the picture of congenital anomalies in Wales. Assess interventions intended to help prevent or detect congenital anomalies. Plan and coordinate provision of health services for affected babies and children. Assess possible clusters of birth defects and their causes.
The register has a lead clinician, who is an obstetrician and a director of information, and who is a consultant in Public Health.
In 2005, an expert advisory group was set up to help set objectives for the register. The group consists of a fetal medicine consultant, an obstetrician, a pediatrician, a medical geneticist, a consultant radiologist, a lay representative, a consultant in public health, the director of Antenatal Screening Wales, and a senior medical officer from the Welsh Assembly Government. The group meets twice yearly.
Population Coverage
The registry is population-based and covers the entire country of Wales with an annual number of births of currently around 35,000.
Sources of Ascertainment
Reporting is voluntary. The register relies upon multisource reporting including antenatal clinics, delivery units, pediatric departments, ophthalmology, cytogenetics, pathology, orthopedics, and maxillofacial and regional centers of pediatric surgery. Each delivery unit has a nominated coordinator to help ensure good reporting. Register staff also visit units to help with data collection. Registration covers all fetuses with prenatally diagnosed anomalies. There is no lower age limit so fetal losses and early terminations with anomalies are registered. All live born babies with structural anomalies are registered if diagnosed before their first birthday, but all chromosomal anomalies and syndromes are registered, even if diagnosed later.
Babies in North Wales needing specialist services are referred to Liverpool and in South Wales, they travel to Bristol for cardiac surgery. Both pediatric cardiology centers in Cardiff and Liverpool supply systematic case lists and diagnostic details to the registry, including details of antenatally-detected cases. These lists cover the whole population requiring pediatric cardiology services and are provided annually.
The cytogenetic laboratory in Cardiff provides a download of data of all abnormal karyotypes on a quarterly basis. This includes details of demographic details, procedure, and reason for karyotying. Cases reported include antenatal and all children born since 1998. This covers most of the population. Some cases in North Wales are karyotyped in Liverpool, while a few cases in Mid Wales are referred via Shrewsbury to Birmingham. This means that the register cannot guarantee 100% coverage of the Welsh population; although many of these cases are known and reported back to the register.
Maximum Age at Diagnosis
Maximum age at diagnosis is set at 1 year of age. This is currently under review. Chromosomal anomalies and syndromes are an exception to this rule. In these cases, it is often found that a registration has already been made for other anomalies diagnosed within the first year.
Electronic reporting of inpatient data has presented a challenge, as it has highlighted unreported cases from years before. It is not always clear precisely when the diagnosis was originally made. These cases require followup to ensure that the diagnosis is correct as well as to verify the time of diagnosis. Regular data downloads should lessen this problem in the future and give better ascertainment.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal under certain grounds up to 24 weeks of gestation. If congenital anomaly is diagnosed, there is no upper gestational age limit for termination in cases of major anomaly. Terminations of pregnancy for fetal anomaly are registered whatever the gestational age.
Stillbirth Definition and Early Fetal Deaths
Stillbirth definition is 24 weeks' gestation (late fetal death after 23 weeks 1 6 days gestation). Stillbirths of 24 weeks or more are registered. Early fetal deaths/spontaneous abortions have no lower limit for inclusion on the register (earliest recorded is 8 weeks' gestation).
Exposure Data Availability
Exposure information on maternal drug use, smoking, alcohol, maternal and paternal diseases and occupations, outcomes of previous pregnancies, and assisted conception is available. Folic acid supplementation before and during pregnancy is also collected. Drugs are coded to the ATC classification. Since 2005, body mass index has also been added to the dataset.
Denominators and Controls Information
Denominator data is obtained from the Office for National Statistics. Where this is not timely or readily available, then data may be used from the National Community Child Health System.
Registry Description Reference
The registry's description and work was most recently described in our 10th annual report. This is available on: www.wales.nhs.uk/sites3/Documents/416/Caris%20Ann%20rep%20%28Eng%29%20final.pdf.
Ethics and Consent
The registry requires ethics committee approval to collect and store data and this comes from Leicester Regional Multicentre Research Ethics Committee, under
Registry Contribution to EUROCAT Collaborative
Address for Further Information
David Tucker, Public Health Wales, Congenital Anomaly Register and Information Service for Wales (CARIS), Level 3 -West Wing, Singleton Hospital, Sketty Lane, Swansea, SA2 8QA. E-mail: david.tucker2@wales.nhs.uk.
UNITED KINGDOM, WESSEX -FULL MEMBER
History and Funding
The Wessex Antenatally Detected Anomalies Register (WANDA) was started in 1988 as a local database. In 1994, funding was obtained and the regional register established under the auspices of the Wessex Clinical Genetics Service. Funding is provided by each of the 10 districts covered through the genetics budget. The registry joined EUROCAT in 2002, and has sent backdated data from 1994. From 2001, data have been transmitted electronically to the ONS. WANDA is an active member of BINOCAR and the Follow-up of Congenital Anomalies Long-term study (FOCAL). Data collection is enhanced by regular specialized meetings in each district. Thus, the aims of WANDA are to improve communication between all clinicians involved in the care of pregnant women and their babies; to monitor clusters and provide relevant data to allow further investigation and research; to evaluate new and established prenatal screening tests; to monitor incidence and population trends of selected malformations; to provide data for research into the etiology and natural history of certain anomalies and for the investigation of potential teratogens; and to provide data for health care policies and planning.
Population Coverage
All women living within the old 'Wessex' region, Jersey and Guernsey, who deliver within the hospitals in the region are included (population-based III). Annual births are approximately 27,000 and the population is 2.8 million.
Sources of Ascertainment
Information is collected on all fetuses in which an anomaly, a suspected anomaly, or an ultrasound soft marker, has been detected antenatally. Data are also ascertained on all babies born with a congenital anomaly or a genetic condition. Anomalies are accepted at any age of detection, but in reality, reporting is unreliable if diagnosed outside the neonatal period. Exceptions are chromosome errors and surgical conditions for which the register has full ascertainment at any age. All cardiac defects detected antenatally and those that require treatment or further investigation postnatally are included in the register, hence, small ventricular septal defects, mild pulmonary stenosis, and other conditions with minimal or no morbidity are not included. This information is available directly from the cardiology department.
Reporting of hypospadias is good from January 2001 but was poor until this date.
The cytogenetic laboratories provide data on all abnormal prenatal and infant karyotypes (and now array comparative genomic hybridization results) for the entire population covered by WANDA. Routine downloads are also sent on all cases every 6 months to ensure no case is missed.
Data are obtained voluntarily from multiple sources. Sources used include ultrasonographers, radiologists, obstetricians, fetal medicine, pediatricians, pediatric cardiologists, pediatric surgeons, pediatric neurologists, pediatric pathologists, plastic surgeons, orthopaedic nurse, CESDI (Confidential Enquiry into Stillbirths and Deaths in Infancy), central records for Primary Care Trusts for postnatal cases, cytogenetics, molecular genetics, clinical genetics, pathologists, and biochemistry. Ascertainment is excellent for anomalies detected antenatally but less complete for those diagnosed postnatally. Both active and passive ascertainment procedures are used. Data are good where there has been a postmortem examination, for all significant cardiac and chromosomal defects, and for all conditions requiring surgery such as abdominal wall defects or clefts. Ascertainment is incomplete for neurologic and orthopedic conditions, although serious efforts are underway to improve these. Cerebral palsy or isolated hearing or sight impairment are not included.
Maximum Age at Diagnosis
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal up to 24 weeks of gestation with no gestation limit for very serious congenital anomalies. Cases are ascertained from the department of fetal medicine and from postmortem reports.
Stillbirth Definition and Early Fetal Deaths
The definition of stillbirth is ''a child born with no signs of life after complete expulsion from the mother after the 24th week of pregnancy.'' All stillbirths with a congenital anomaly are registered. Early fetal deaths/ spontaneous abortions are included with no lower gestational age limit.
Exposures Data Availability
Information is collected where it is available (not on every case) on chronic illness in the mother, details of assisted conception, invasive tests in pregnancy, and alcohol abuse. In practice, this information is very underreported.
Denominators and Controls Information
Data on the number of births in each district are provided through the labor wards of each hospital (i.e., referring to the births in each hospital to residents of the region). Maternal age is supplied by ONS with at least a one year delay. No control information is collected.
Ethics and Consent
National legislation requires informed consent but the registry is exempt. National Information Governance Board approval (formerly PIAG) -Health & Social Care Act 2001 -allows for the Secretary of State for Health to permit certain data to be collected without consent. However, parents/patients can opt-out of registers.
Electronic and Web-based Data Capture
The register is able to access other data sources electronically for information but we do not receive regular case reports through this route.
Local Studies
Outcome of fetal 'absent stomach' or 'small stomach' found at routine ultrasound scan.
Prenatal detection rate of postnatally diagnosed esophageal atresia 1/-tracheo-esophageal fistula.
Long-term outcome of duodenal atresia. Prenatal detection of heart abnormalities in Wessex.
National Studies
With four other U.K. registers and the Small Areas Health Authority Unit at Imperial College, 'chlorination disinfection byproducts and risk of congenital anomalies in England and Wales' study. Complete and published.
The Follow-up of Congenital Anomalies Long-term study, under the umbrella of the National Perinatal Epidemiology Unit in Oxford, commenced in 2006 with funding from Newlife. 'Etiology of gastroschisis: a prospective case control study to investigate the effects of lifestyle, dietary, and environmental exposures.' Case collection is complete but the control data are still awaited.
In conjunction with the Department of Experimental Psychology in Oxford, Clinical Genetics and the local congenital anomaly registers in Southampton, Oxford, Bristol, Manchester, and London, and the parental support group Unique, children aged from 4 to 16 years who were diagnosed prenatally with a sex chromosome anomaly were followed up. The findings from this study have been published.
We thank the many people throughout Europe involved in providing and processing information, including affected families, clinicians, health professionals, medical records clerks, and registry staff.
